SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '113'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_A_DCFA353_1 (ADENOSINE DEAMINASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 12 | HIS A 55HIS A 96PHE A 19PHE A 44ALA A 108 | MN A1132 (-3.4A) MN A1132 (-3.4A)NoneNoneNone | 1.21A | 1a4lA-4bifA:undetectable | 1a4lA-4bifA:17.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_C_DCFC1353_1 (ADENOSINE DEAMINASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 12 | HIS A 55HIS A 96PHE A 19PHE A 44ALA A 108 | MN A1132 (-3.4A) MN A1132 (-3.4A)NoneNoneNone | 1.21A | 1a4lC-4bifA:undetectable | 1a4lC-4bifA:17.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBR_A_REAA200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE I) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19THR A 56VAL A 60ARG A 129TYR A 131 | NoneA9M A1136 ( 4.3A)A9M A1136 (-4.8A)A9M A1136 (-4.3A)A9M A1136 (-4.8A) | 0.89A | 1cbrA-4azpA:19.5 | 1cbrA-4azpA:33.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBR_B_REAB200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE I) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19THR A 56VAL A 60ARG A 129TYR A 131 | NoneA9M A1136 ( 4.3A)A9M A1136 (-4.8A)A9M A1136 (-4.3A)A9M A1136 (-4.8A) | 0.89A | 1cbrB-4azpA:19.6 | 1cbrB-4azpA:33.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E7A_A_PFLA4001_1 (SERUM ALBUMIN) |
4x0o | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 3 PROTEIN 2 (Vibriocholerae) | 5 / 9 | LEU A 261ILE A 257LEU A 117GLY A 312ALA A 223 | NoneNoneNoneSCY A 113 ( 3.1A)None | 1.26A | 1e7aA-4x0oA:undetectable | 1e7aA-4x0oA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EII_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN II) |
3p8c | NCK-ASSOCIATEDPROTEIN 1 (Homosapiens) | 5 / 12 | THR B 536ARG B 343LEU B 375LEU B 408LEU B 230 | None CL B1131 (-3.8A)NoneNoneNone | 1.25A | 1eiiA-3p8cB:undetectable | 1eiiA-3p8cB:7.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EQG_A_IBPA701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
3o5t | PII-LIKE PROTEIN PZ (Azospirillumbrasilense) | 5 / 9 | VAL B 63VAL B 16LEU B 20ILE B 91ALA B 6 | ADP B 113 (-4.1A)NoneNoneNoneNone | 0.96A | 1eqgA-3o5tB:undetectable | 1eqgA-3o5tB:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EQG_B_IBPB1701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
3o5t | PII-LIKE PROTEIN PZ (Azospirillumbrasilense) | 5 / 11 | VAL B 63VAL B 16LEU B 20ILE B 91ALA B 6 | ADP B 113 (-4.1A)NoneNoneNoneNone | 0.97A | 1eqgB-3o5tB:undetectable | 1eqgB-3o5tB:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EQH_A_FLPA701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
3o5t | PII-LIKE PROTEIN PZ (Azospirillumbrasilense) | 5 / 12 | VAL B 63VAL B 16LEU B 20ILE B 91ALA B 6 | ADP B 113 (-4.1A)NoneNoneNoneNone | 0.96A | 1eqhA-3o5tB:undetectable | 1eqhA-3o5tB:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EQH_B_FLPB1701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
3o5t | PII-LIKE PROTEIN PZ (Azospirillumbrasilense) | 5 / 12 | VAL B 63VAL B 16LEU B 20ILE B 91ALA B 6 | ADP B 113 (-4.1A)NoneNoneNoneNone | 0.97A | 1eqhB-3o5tB:undetectable | 1eqhB-3o5tB:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1F9G_A_ASCA950_0 (HYALURONATE LYASE) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 4 / 7 | ARG A 71ASN A 199TYR A 260ASN A 235 | NoneGAL A1130 (-3.5A)GAL A1130 (-4.5A)GAL A1130 (-4.6A) | 1.50A | 1f9gA-4iugA:undetectable | 1f9gA-4iugA:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FBM_B_RTLB951_1 (PROTEIN (CARTILAGEOLIGOMERIC MATRIXPROTEIN)) |
5lmx | DNA-DIRECTED RNAPOLYMERASES I ANDIII SUBUNITRPAC1,DNA-DIRECTEDRNA POLYMERASES IAND III SUBUNITRPAC1 (Saccharomycescerevisiae) | 4 / 4 | THR C 114LEU C 113VAL C 78LEU C 106 | THR C 114 ( 0.8A)LEU C 113 ( 0.6A)VAL C 78 ( 0.6A)LEU C 106 ( 0.5A) | 0.97A | 1fbmB-5lmxC:undetectable | 1fbmB-5lmxC:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FML_B_RTLB501_0 (RETINOL DEHYDRATASE) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 5 / 12 | ILE A 72LEU A 80HIS A 99HIS A 223TYR A 40 | NoneNone ZN A1001 (-3.4A)113 A2002 ( 3.6A)None | 1.23A | 1fmlB-1hlkA:undetectable | 1fmlB-1hlkA:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1G50_A_ESTA600_1 (ESTROGEN RECEPTOR) |
3wd7 | TYPE III POLYKETIDESYNTHASES ACRIDONESYNTHASE (Citrusxmicrocarpa) | 5 / 11 | LEU A 222ALA A 113GLU A 116ARG A 234LEU A 187 | LEU A 222 ( 0.6A)ALA A 113 ( 0.0A)GLU A 116 ( 0.5A)ARG A 234 ( 0.6A)LEU A 187 ( 0.5A) | 1.21A | 1g50A-3wd7A:undetectable | 1g50A-3wd7A:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HK1_A_T44A3004_1 (SERUM ALBUMIN) |
5xyi | 40S RIBOSOMALPROTEIN SA (Trichomonasvaginalis) | 4 / 6 | PHE A 101GLU A 134VAL A 72MET A 120 | None A 21131 ( 3.1A)NoneNone | 1.06A | 1hk1A-5xyiA:undetectable | 1hk1A-5xyiA:19.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HSH_A_MK1A401_1 (HIV-II PROTEASE) |
2w3j | CARBOHYDRATE BINDINGMODULE (unculturedbacterium) | 6 / 12 | GLY A 60ASP A 32ILE A 31GLY A 29ILE A 124ILE A 121 | None CA A1138 (-3.3A)None CA A1139 (-4.4A)NoneNone | 1.40A | 1hshA-2w3jA:undetectable | 1hshA-2w3jA:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HVY_B_D16B415_1 (THYMIDYLATE SYNTHASE) |
4x0o | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 3 PROTEIN 2 (Vibriocholerae) | 5 / 12 | ILE A 257ASN A 281GLY A 216PHE A 220ALA A 313 | NoneSCY A 113 ( 3.7A)NoneNoneSCY A 113 ( 3.9A) | 1.35A | 1hvyB-4x0oA:undetectable | 1hvyB-4x0oA:23.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1I2W_A_CFXA1300_2 (BETA-LACTAMASE) |
2ktq | PROTEIN (LARGEFRAGMENT OF DNAPOLYMERASE I) (Thermusaquaticus) | 4 / 5 | TYR A 671LEU A 622THR A 571ARG A 728 | DCT A 113 (-4.7A)NoneNoneNone | 1.31A | 1i2wA-2ktqA:undetectable | 1i2wA-2ktqA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IWH_A_PEMA501_1 (HEMOGLOBIN ALPHACHAIN) |
1c8x | ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H (Streptomycesplicatus) | 4 / 6 | ALA A 110LYS A 113ASP A 117ALA A 118 | ALA A 110 ( 0.0A)LYS A 113 ( 0.0A)ASP A 117 ( 0.6A)ALA A 118 ( 0.0A) | 0.23A | 1iwhA-1c8xA:undetectable | 1iwhA-1c8xA:20.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JB0_B_PQNB2002_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 9 / 11 | TRP A 55MET A 691PHE A 692SER A 695ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.59A | 1jb0B-4rkuA:33.6 | 1jb0B-4rkuA:45.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHQ_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 4 / 8 | GLY A1035GLY A1030ARG A1034GLY A1032 | NoneIPA A1135 ( 4.4A)NoneNone | 0.72A | 1jhqA-1mc2A:undetectable | 1jhqA-1mc2A:15.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
4x0o | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 3 PROTEIN 2 (Vibriocholerae) | 5 / 11 | ILE A 257ASN A 281GLY A 216PHE A 220ALA A 313 | NoneSCY A 113 ( 3.7A)NoneNoneSCY A 113 ( 3.9A) | 1.36A | 1ju6A-4x0oA:undetectable | 1ju6A-4x0oA:24.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JU6_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4x0o | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 3 PROTEIN 2 (Vibriocholerae) | 5 / 10 | ILE A 257ASN A 281GLY A 216PHE A 220ALA A 313 | NoneSCY A 113 ( 3.7A)NoneNoneSCY A 113 ( 3.9A) | 1.36A | 1ju6C-4x0oA:undetectable | 1ju6C-4x0oA:24.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KT6_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
3ab7 | PUTATIVEUNCHARACTERIZEDPROTEIN TTHA0350 (Thermusthermophilus) | 5 / 11 | LEU A 137ALA A 170VAL A 136LEU A 113ARG A 117 | LEU A 137 ( 0.6A)ALA A 170 ( 0.0A)VAL A 136 ( 0.6A)LEU A 113 ( 0.6A)ARG A 117 ( 0.6A) | 1.43A | 1kt6A-3ab7A:undetectable | 1kt6A-3ab7A:19.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJ2_A_SAMA2201_1 (PROTEIN (METHIONINEREPRESSOR)) |
5xxu | RIBOSOMAL PROTEINUS12 (Toxoplasmagondii) | 4 / 4 | HIS X 110ALA X 111PHE X 105GLY X 109 | U 21131 ( 4.3A) U 21131 ( 4.7A)NoneNone | 1.38A | 1mj2B-5xxuX:undetectable | 1mj2B-5xxuX:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJO_A_SAMA199_1 (METHIONINE REPRESSOR) |
5xxu | RIBOSOMAL PROTEINUS12 (Toxoplasmagondii) | 4 / 4 | HIS X 110ALA X 111PHE X 105GLY X 109 | U 21131 ( 4.3A) U 21131 ( 4.7A)NoneNone | 1.38A | 1mjoB-5xxuX:undetectable | 1mjoB-5xxuX:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJO_B_SAMB200_0 (METHIONINE REPRESSOR) |
5xxu | RIBOSOMAL PROTEINUS12 (Toxoplasmagondii) | 4 / 4 | HIS X 110ALA X 111PHE X 105GLY X 109 | U 21131 ( 4.3A) U 21131 ( 4.7A)NoneNone | 1.35A | 1mjoA-5xxuX:undetectable | 1mjoA-5xxuX:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJO_D_SAMD200_1 (METHIONINE REPRESSOR) |
5xxu | RIBOSOMAL PROTEINUS12 (Toxoplasmagondii) | 4 / 4 | HIS X 110ALA X 111PHE X 105GLY X 109 | U 21131 ( 4.3A) U 21131 ( 4.7A)NoneNone | 1.41A | 1mjoD-5xxuX:undetectable | 1mjoD-5xxuX:19.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MX8_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN I, HOLO) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 12 | PHE A 17TYR A 20ALA A 34PRO A 39THR A 54 | NoneNone NA A1132 ( 4.0A)NoneNone | 0.93A | 1mx8A-4a60A:16.3 | 1mx8A-4a60A:31.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MX8_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN I, HOLO) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19TYR A 22ALA A 36PRO A 41THR A 56 | NoneNoneA9M A1136 (-3.4A)A9M A1136 ( 4.7A)A9M A1136 ( 4.3A) | 1.03A | 1mx8A-4azpA:16.9 | 1mx8A-4azpA:32.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N2X_A_SAMA401_0 (S-ADENOSYL-METHYLTRANSFERASE MRAW) |
1zu4 | FTSY (Mycoplasmamycoides) | 5 / 12 | GLY A 203GLY A 208VAL A 344VAL A 202ARG A 236 | NoneSO4 A1130 (-3.7A)NoneNoneSO4 A1130 (-3.9A) | 1.28A | 1n2xA-1zu4A:undetectable | 1n2xA-1zu4A:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OT7_A_CHCA1001_1 (BILE ACID RECEPTOR) |
2wu5 | SUCCINATEDEHYDROGENASECYTOCHROME B556SUBUNIT (Escherichiacoli) | 5 / 12 | SER C 33ILE C 36ILE C 28TYR C 83HIS C 91 | NoneNoneCBE C1130 (-4.0A)NoneHEM C 305 (-3.2A) | 1.49A | 1ot7A-2wu5C:1.8 | 1ot7A-2wu5C:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QLT_A_ACTA601_0 (VANILLYL-ALCOHOLOXIDASE) |
2wsh | ENDONUCLEASE II (EscherichiavirusT4) | 4 / 5 | TYR A 61ILE A 39TYR A 37ARG A 57 | NoneNonePO4 A1133 (-4.7A)PO4 A1133 (-3.6A) | 1.29A | 1qltA-2wshA:0.0 | 1qltA-2wshA:13.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SDT_B_MK1B902_1 (PROTEASE RETROPEPSIN) |
2f4i | HYPOTHETICAL PROTEINTM0957 (Thermotogamaritima) | 5 / 10 | LEU A 125GLY A 180ILE A 213VAL A 112ILE A 110 | NoneNoneNoneMLY A 113 ( 2.9A)None | 0.96A | 1sdtA-2f4iA:undetectable | 1sdtA-2f4iA:17.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1T6Z_A_RBFA296_1 (RIBOFLAVINKINASE/FMNADENYLYLTRANSFERASE) |
5nbs | BETA-GLUCOSIDASE (Neurosporacrassa) | 5 / 11 | VAL A 530ASN A 478GLU A 525GLU A 418ILE A 484 | NoneNoneBMA A1134 (-3.6A)NoneNone | 1.47A | 1t6zA-5nbsA:undetectable | 1t6zA-5nbsA:13.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1T9U_A_CPFA5002_1 (ACRIFLAVINERESISTANCE PROTEIN B) |
3umm | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE (Salmonellaenterica) | 4 / 6 | PHE A1094ASN A1136ASN A 474GLN A1048 | CYG A1135 ( 3.1A)CYG A1135 ( 4.4A)NoneNone | 1.21A | 1t9uA-3ummA:5.0 | 1t9uA-3ummA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VQ1_A_SAMA301_1 (N5-GLUTAMINEMETHYLTRANSFERASE,HEMK) |
1jpc | AGGLUTININ (Galanthusnivalis) | 3 / 3 | GLY A 78ASP A 59ASN A 76 | MAN A 113 ( 4.8A)MAN A 113 (-3.2A)MAN A 114 (-3.1A) | 0.53A | 1vq1A-1jpcA:undetectable | 1vq1A-1jpcA:16.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VQ1_A_SAMA301_1 (N5-GLUTAMINEMETHYLTRANSFERASE,HEMK) |
3dzw | AGGLUTININ (Narcissuspseudonarcissus) | 3 / 3 | GLY A 46ASP A 28ASN A 44 | MAN A 113 ( 4.7A)MAN A 113 (-3.1A)None | 0.58A | 1vq1A-3dzwA:undetectable | 1vq1A-3dzwA:15.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1WOP_A_FFOA2887_0 (AMINOMETHYLTRANSFERASE) |
1wsv | AMINOMETHYLTRANSFERASE (Homosapiens) | 6 / 12 | MET A 56TYR A 113VAL A 115ASN A 117TYR A 197ARG A 233 | MET A 56 (-0.0A)TYR A 113 ( 1.3A)VAL A 115 (-0.6A)ASN A 117 (-0.6A)TYR A 197 (-1.3A)ARG A 233 (-0.6A) | 1.15A | 1wopA-1wsvA:50.1 | 1wopA-1wsvA:34.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1WOP_A_FFOA2887_0 (AMINOMETHYLTRANSFERASE) |
1wsv | AMINOMETHYLTRANSFERASE (Homosapiens) | 5 / 12 | VAL A 115TYR A 113ASN A 117TYR A 197ARG A 233 | VAL A 115 (-0.6A)TYR A 113 ( 1.3A)ASN A 117 (-0.6A)TYR A 197 (-1.3A)ARG A 233 (-0.6A) | 1.48A | 1wopA-1wsvA:50.1 | 1wopA-1wsvA:34.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WSV_B_THHB4001_0 (AMINOMETHYLTRANSFERASE) |
1hkq | REPLICATION PROTEIN (Pseudomonassavastanoi) | 5 / 12 | THR A 47LEU A 109ILE A 48CYH A 29LEU A 75 | HG A1133 ( 4.8A)NoneNone HG A1135 (-2.3A)None | 1.36A | 1wsvB-1hkqA:undetectable | 1wsvB-1hkqA:18.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XL6_B_SPMB3001_1 (INWARD RECTIFIERPOTASSIUM CHANNEL) |
5xyi | 40S RIBOSOMALPROTEIN S2140S RIBOSOMALPROTEIN SA (Trichomonasvaginalis) | 4 / 5 | ALA V 30TYR A 137ALA V 60GLN A 130 | None G 21104 ( 4.6A) G 2 891 ( 3.6A) A 21131 ( 3.6A) | 1.00A | 1xl6A-5xyiV:undetectable1xl6B-5xyiV:undetectable | 1xl6A-5xyiV:13.951xl6B-5xyiV:13.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XVA_A_ACTA294_0 (GLYCINEN-METHYLTRANSFERASE) |
4dlk | PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXYLASE, ATPASESUBUNIT (Bacillusanthracis) | 4 / 5 | ILE A 266LEU A 246ALA A 113GLU A 110 | ILE A 266 ( 0.7A)LEU A 246 ( 0.6A)ALA A 113 ( 0.0A)GLU A 110 ( 0.6A) | 1.29A | 1xvaA-4dlkA:2.81xvaB-4dlkA:2.6 | 1xvaA-4dlkA:20.901xvaB-4dlkA:20.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Y4L_B_SVRB301_1 (PHOSPHOLIPASE A2HOMOLOG 2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 5 / 12 | LEU A1002GLY A1023ARG A1034TYR A1052LYS A1069 | IPA A1136 ( 4.7A)IPA A1135 ( 4.1A)NoneNoneNone | 0.83A | 1y4lA-1mc2A:23.8 | 1y4lA-1mc2A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Y4L_B_SVRB301_1 (PHOSPHOLIPASE A2HOMOLOG 2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 8 / 12 | LEU A1002GLY A1023GLY A1030GLY A1033ARG A1034LYS A1049TYR A1052LYS A1070 | IPA A1136 ( 4.7A)IPA A1135 ( 4.1A)IPA A1135 ( 4.4A)NoneNoneNoneNoneNone | 0.62A | 1y4lA-1mc2A:23.8 | 1y4lA-1mc2A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Y4L_B_SVRB301_2 (PHOSPHOLIPASE A2HOMOLOG 2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 6 / 11 | LEU A1002LEU A1005GLY A1032HIS A1048TYR A1052LYS A1070 | IPA A1136 ( 4.7A)IPA A1135 ( 4.2A)NoneNoneNoneNone | 0.82A | 1y4lB-1mc2A:23.1 | 1y4lB-1mc2A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Y4L_B_SVRB301_2 (PHOSPHOLIPASE A2HOMOLOG 2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 9 / 11 | LEU A1002LEU A1005VAL A1031GLY A1033ARG A1034HIS A1048LYS A1049TYR A1052LYS A1070 | IPA A1136 ( 4.7A)IPA A1135 ( 4.2A)NoneNoneNoneNoneNoneNoneNone | 0.57A | 1y4lB-1mc2A:23.1 | 1y4lB-1mc2A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Y4L_B_SVRB301_2 (PHOSPHOLIPASE A2HOMOLOG 2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 5 / 11 | LEU A1005ARG A1034HIS A1048TYR A1052LYS A1053 | IPA A1135 ( 4.2A)NoneNoneNoneNone | 1.29A | 1y4lB-1mc2A:23.1 | 1y4lB-1mc2A:75.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AVV_A_MK1A901_2 (POL POLYPROTEIN) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 3 / 3 | ASP A 17VAL A 25PRO A 76 | NoneNonePLM A1136 (-4.6A) | 0.78A | 2avvA-1o8vA:undetectable | 2avvA-1o8vA:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BR4_B_SAMB301_0 (CEPHALOSPORINHYDROXYLASE CMCI) |
3i4k | MUCONATE LACTONIZINGENZYME (Corynebacteriumglutamicum) | 5 / 12 | GLY A 49ASN A 45ASP A 116ALA A 113ALA A 109 | GLY A 49 ( 0.0A)ASN A 45 ( 0.6A)ASP A 116 ( 0.6A)ALA A 113 ( 0.0A)ALA A 109 ( 0.0A) | 1.28A | 2br4B-3i4kA:undetectable | 2br4B-3i4kA:19.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXD_B_RWFB2001_1 (SERUM ALBUMIN) |
2r5v | PCZA361.1 (Amycolatopsisorientalis) | 5 / 10 | PHE A 29TRP A 23LEU A 156ILE A 322ALA A 243 | NoneNoneNoneNone CO A4113 ( 4.4A) | 1.32A | 2bxdB-2r5vA:0.0 | 2bxdB-2r5vA:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BYO_A_LNLA1217_1 (LIPOPROTEIN LPPX) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 4 / 4 | VAL A 408LEU B 674ILE A 443LEU A 446 | CLA A1128 ( 4.6A)NoneNoneCLA A1137 ( 3.6A) | 0.99A | 2byoA-4rkuA:undetectable | 2byoA-4rkuA:14.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CBR_A_A80A201_1 (PROTEIN (CRABP-I)) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19THR A 56VAL A 60ARG A 129TYR A 131 | NoneA9M A1136 ( 4.3A)A9M A1136 (-4.8A)A9M A1136 (-4.3A)A9M A1136 (-4.8A) | 0.71A | 2cbrA-4azpA:19.7 | 2cbrA-4azpA:33.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2COI_B_GBNB420_1 (BRANCHED CHAINAMINOTRANSFERASE 1,CYTOSOLIC) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 5 / 10 | TYR A 260TYR A 362TYR A 96GLY A 146ALA A 141 | GAL A1130 (-4.5A)NoneGAL A1130 (-4.7A)NoneGAL A1130 (-4.5A) | 1.34A | 2coiA-4iugA:undetectable2coiB-4iugA:undetectable | 2coiA-4iugA:17.512coiB-4iugA:17.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DM6_A_IMNA1401_1 (NADP-DEPENDENTLEUKOTRIENE B412-HYDROXYDEHYDROGENASE) |
1gmm | CBM6 (Ruminiclostridiumthermocellum) | 5 / 10 | TYR A 40ILE A 32PRO A 118GLU A 36ILE A 35 | NoneNone NA A1131 (-4.5A)None NA A1131 (-4.1A) | 1.37A | 2dm6A-1gmmA:undetectable2dm6B-1gmmA:undetectable | 2dm6A-1gmmA:15.642dm6B-1gmmA:15.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DTT_C_H4BC1002_1 (HYPOTHETICAL PROTEINPH0634) |
4chg | PROBABLERIBONUCLEASE VAPC15 (Mycobacteriumtuberculosis) | 4 / 6 | TYR A 117ASP A 116THR A 5GLU A 42 | None MN A1133 (-3.0A)None MG A1134 ( 3.8A) | 0.99A | 2dttB-4chgA:undetectable2dttC-4chgA:undetectable | 2dttB-4chgA:20.292dttC-4chgA:20.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FR3_A_REAA300_1 (CELLULAR RETINOICACID BINDING PROTEIN2) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19PRO A 41THR A 56ARG A 129TYR A 131 | NoneA9M A1136 ( 4.7A)A9M A1136 ( 4.3A)A9M A1136 (-4.3A)A9M A1136 (-4.8A) | 1.02A | 2fr3A-4azpA:19.6 | 2fr3A-4azpA:35.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G70_B_SAMB2002_0 (PHENYLETHANOLAMINEN-METHYLTRANSFERASE) |
6fos | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Cyanidioschyzonmerolae) | 5 / 12 | GLN A 634PHE A 529VAL A 531HIS A 532ALA A 633 | NoneNoneNoneCLA A1135 (-4.3A)None | 1.16A | 2g70B-6fosA:undetectable | 2g70B-6fosA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G72_B_SAMB2002_0 (PHENYLETHANOLAMINEN-METHYLTRANSFERASE) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 6 / 12 | THR A 480GLN A 644PHE A 539LEU A 484VAL A 541HIS A 542 | NoneNoneCLA A1136 (-4.7A)NoneNoneCLA A1136 ( 3.3A) | 1.48A | 2g72B-4rkuA:undetectable | 2g72B-4rkuA:16.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G72_B_SAMB2002_0 (PHENYLETHANOLAMINEN-METHYLTRANSFERASE) |
6fos | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Cyanidioschyzonmerolae) | 5 / 12 | GLN A 634PHE A 529VAL A 531HIS A 532ALA A 633 | NoneNoneNoneCLA A1135 (-4.3A)None | 1.23A | 2g72B-6fosA:undetectable | 2g72B-6fosA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JN3_A_JN3A130_2 (FATTY ACID-BINDINGPROTEIN, LIVER) |
2cjt | UNC-13 HOMOLOG A (Rattusnorvegicus) | 4 / 7 | PHE A 49LEU A 26LEU A 60GLU A 46 | FMT A1139 ( 4.3A)NoneNoneNone | 1.05A | 2jn3A-2cjtA:undetectable | 2jn3A-2cjtA:24.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NOA_A_3TCA302_1 (DEOXYCYTIDINE KINASE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 12 | ILE A 105GLU A 73LEU A 24TYR A 20ALA A 76 | NoneNoneNoneNoneEDO A1134 ( 3.9A) | 0.92A | 2noaA-4a60A:undetectable | 2noaA-4a60A:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NOA_A_3TCA302_1 (DEOXYCYTIDINE KINASE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | ILE A 107GLU A 75LEU A 26TYR A 22ALA A 78 | A9M A1136 (-4.4A)NoneNoneNoneA9M A1136 (-3.5A) | 1.12A | 2noaA-4azpA:undetectable | 2noaA-4azpA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYR_B_SVRB401_3 (NAD-DEPENDENTDEACETYLASESIRTUIN-5) |
3umm | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE (Salmonellaenterica) | 5 / 12 | TYR A1222ILE A1192HIS A1260GLY A1197ASN A 378 | NoneNoneCYG A1135 ( 3.6A)CYG A1135 ( 3.8A)None | 1.49A | 2nyrB-3ummA:3.3 | 2nyrB-3ummA:11.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O4P_A_TPVA300_2 (PROTEASE) |
2f4i | HYPOTHETICAL PROTEINTM0957 (Thermotogamaritima) | 5 / 9 | LEU A 125GLY A 180ILE A 213VAL A 112ILE A 110 | NoneNoneNoneMLY A 113 ( 2.9A)None | 0.97A | 2o4pB-2f4iA:undetectable | 2o4pB-2f4iA:17.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OCF_A_ESTA596_1 (ESTROGEN RECEPTOR) |
3wd7 | TYPE III POLYKETIDESYNTHASES ACRIDONESYNTHASE (Citrusxmicrocarpa) | 5 / 10 | LEU A 222ALA A 113GLU A 116ARG A 234LEU A 187 | LEU A 222 ( 0.6A)ALA A 113 ( 0.0A)GLU A 116 ( 0.5A)ARG A 234 ( 0.6A)LEU A 187 ( 0.5A) | 1.25A | 2ocfA-3wd7A:undetectable | 2ocfA-3wd7A:23.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QEO_A_LNRA200_1 (D7R4 PROTEIN) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 5 / 12 | GLU A 804TYR A 342ILE A 139VAL A 143TYR A 96 | CD A1108 (-2.3A)GAL A1130 (-4.2A)NoneNoneGAL A1130 (-4.7A) | 1.43A | 2qeoA-4iugA:undetectable | 2qeoA-4iugA:8.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QHF_A_ACTA502_0 (CHORISMATE SYNTHASE) |
4aud | MAJOR ALLERGEN ALT A1 SUBUNIT (Alternariaalternata) | 3 / 3 | GLY A 73ASP A 56SER A 71 | SO4 A1130 (-3.3A)NoneNone | 0.69A | 2qhfA-4audA:undetectable | 2qhfA-4audA:14.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 6 / 12 | PHE A 16VAL A 25SER A 54ASP A 77ARG A 79ARG A 127 | PLM A1136 (-4.7A)NonePLM A1136 ( 4.9A)PLM A1136 (-3.8A)PLM A1136 (-4.6A)PLM A1136 (-4.4A) | 1.16A | 2qm9A-1o8vA:23.5 | 2qm9A-1o8vA:36.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 9 / 12 | PHE A 16VAL A 25SER A 54SER A 56THR A 61ASP A 77ARG A 79ARG A 127TYR A 129 | PLM A1136 (-4.7A)NonePLM A1136 ( 4.9A)PLM A1136 ( 3.8A)NonePLM A1136 (-3.8A)PLM A1136 (-4.6A)PLM A1136 (-4.4A)PLM A1136 (-4.6A) | 0.54A | 2qm9A-1o8vA:23.5 | 2qm9A-1o8vA:36.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 10 / 12 | PHE A 17VAL A 26ALA A 34SER A 56THR A 61ASP A 77ARG A 79CYH A 118ARG A 127TYR A 129 | NoneNone NA A1132 ( 4.0A) NA A1132 (-2.9A)NoneEDO A1134 (-3.7A)EDO A1134 ( 4.9A)NoneNoneNone | 0.79A | 2qm9A-4a60A:24.3 | 2qm9A-4a60A:55.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 10 / 12 | PHE A 17VAL A 26SER A 56THR A 61ALA A 76ASP A 77ARG A 79CYH A 118ARG A 127TYR A 129 | NoneNone NA A1132 (-2.9A)NoneEDO A1134 ( 3.9A)EDO A1134 (-3.7A)EDO A1134 ( 4.9A)NoneNoneNone | 0.73A | 2qm9A-4a60A:24.3 | 2qm9A-4a60A:55.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 12 | VAL A 26ALA A 34THR A 54ASP A 77ARG A 79 | None NA A1132 ( 4.0A)NoneEDO A1134 (-3.7A)EDO A1134 ( 4.9A) | 1.11A | 2qm9A-4a60A:24.3 | 2qm9A-4a60A:55.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19ALA A 37CYH A 120ARG A 129TYR A 131 | NoneNoneA9M A1136 ( 3.8A)A9M A1136 (-4.3A)A9M A1136 (-4.8A) | 1.36A | 2qm9A-4azpA:24.3 | 2qm9A-4azpA:48.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 11 / 12 | PHE A 19VAL A 28ALA A 36SER A 58THR A 63ALA A 78ASP A 79ARG A 81CYH A 120ARG A 129TYR A 131 | NoneNoneA9M A1136 (-3.4A)A9M A1136 ( 4.1A)NoneA9M A1136 (-3.5A)A9M A1136 (-4.0A)NoneA9M A1136 ( 3.8A)A9M A1136 (-4.3A)A9M A1136 (-4.8A) | 0.50A | 2qm9A-4azpA:24.3 | 2qm9A-4azpA:48.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 7 / 12 | VAL A 28ALA A 36SER A 58ALA A 78ASP A 79CYH A 127TYR A 131 | NoneA9M A1136 (-3.4A)A9M A1136 ( 4.1A)A9M A1136 (-3.5A)A9M A1136 (-4.0A)NoneA9M A1136 (-4.8A) | 1.25A | 2qm9A-4azpA:24.3 | 2qm9A-4azpA:48.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 4 / 4 | TYR A 20MET A 21PRO A 39ILE A 105 | NoneEDO A1134 (-4.5A)NoneNone | 0.48A | 2qm9A-4a60A:24.3 | 2qm9A-4a60A:55.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 4 / 4 | TYR A 22MET A 23PRO A 41ILE A 107 | NoneA9M A1136 (-3.7A)A9M A1136 ( 4.7A)A9M A1136 (-4.4A) | 0.63A | 2qm9A-4azpA:24.3 | 2qm9A-4azpA:48.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 5 / 12 | PHE A 16VAL A 25SER A 54ARG A 79ARG A 127 | PLM A1136 (-4.7A)NonePLM A1136 ( 4.9A)PLM A1136 (-4.6A)PLM A1136 (-4.4A) | 1.13A | 2qm9B-1o8vA:24.2 | 2qm9B-1o8vA:36.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 8 / 12 | PHE A 16VAL A 25SER A 54SER A 56THR A 61ARG A 79ARG A 127TYR A 129 | PLM A1136 (-4.7A)NonePLM A1136 ( 4.9A)PLM A1136 ( 3.8A)NonePLM A1136 (-4.6A)PLM A1136 (-4.4A)PLM A1136 (-4.6A) | 0.58A | 2qm9B-1o8vA:24.2 | 2qm9B-1o8vA:36.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 8 / 12 | PHE A 16VAL A 25SER A 54SER A 56THR A 61ILE A 105ARG A 127TYR A 129 | PLM A1136 (-4.7A)NonePLM A1136 ( 4.9A)PLM A1136 ( 3.8A)NoneNonePLM A1136 (-4.4A)PLM A1136 (-4.6A) | 0.65A | 2qm9B-1o8vA:24.2 | 2qm9B-1o8vA:36.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 11 / 12 | PHE A 17TYR A 20VAL A 26SER A 56THR A 61ALA A 76ARG A 79ILE A 105CYH A 118ARG A 127TYR A 129 | NoneNoneNone NA A1132 (-2.9A)NoneEDO A1134 ( 3.9A)EDO A1134 ( 4.9A)NoneNoneNoneNone | 0.74A | 2qm9B-4a60A:24.4 | 2qm9B-4a60A:55.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 12 | TYR A 20VAL A 26THR A 54ARG A 79ILE A 105 | NoneNoneNoneEDO A1134 ( 4.9A)None | 1.22A | 2qm9B-4a60A:24.4 | 2qm9B-4a60A:55.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 11 / 12 | PHE A 19TYR A 22VAL A 28SER A 58THR A 63ALA A 78ARG A 81ILE A 107CYH A 120ARG A 129TYR A 131 | NoneNoneNoneA9M A1136 ( 4.1A)NoneA9M A1136 (-3.5A)NoneA9M A1136 (-4.4A)A9M A1136 ( 3.8A)A9M A1136 (-4.3A)A9M A1136 (-4.8A) | 0.50A | 2qm9B-4azpA:25.0 | 2qm9B-4azpA:48.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | TYR A 22VAL A 28THR A 56ARG A 81ILE A 107 | NoneNoneA9M A1136 ( 4.3A)NoneA9M A1136 (-4.4A) | 1.22A | 2qm9B-4azpA:25.0 | 2qm9B-4azpA:48.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | VAL A 28SER A 58ALA A 78CYH A 127TYR A 131 | NoneA9M A1136 ( 4.1A)A9M A1136 (-3.5A)NoneA9M A1136 (-4.8A) | 1.22A | 2qm9B-4azpA:25.0 | 2qm9B-4azpA:48.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 4 / 4 | MET A 20PRO A 38ASP A 77ARG A 107 | PLM A1136 (-3.5A)NonePLM A1136 (-3.8A)PLM A1136 (-3.9A) | 0.48A | 2qm9B-1o8vA:24.2 | 2qm9B-1o8vA:36.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 4 / 4 | MET A 21PRO A 39ASP A 77ARG A 107 | EDO A1134 (-4.5A)NoneEDO A1134 (-3.7A)None | 0.88A | 2qm9B-4a60A:24.4 | 2qm9B-4a60A:55.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 4 / 4 | MET A 23PRO A 41ASP A 79ARG A 109 | A9M A1136 (-3.7A)A9M A1136 ( 4.7A)A9M A1136 (-4.0A)None | 0.52A | 2qm9B-4azpA:25.0 | 2qm9B-4azpA:48.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QMJ_A_ACRA1001_1 (MALTASE-GLUCOAMYLASE, INTESTINAL) |
2r5v | PCZA361.1 (Amycolatopsisorientalis) | 5 / 12 | ASN A 292ILE A 227ILE A 216PHE A 318HIS A 241 | NoneNoneNoneNone CO A4113 ( 3.4A) | 1.41A | 2qmjA-2r5vA:undetectable | 2qmjA-2r5vA:17.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QO5_A_CHDA131_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2r5v | PCZA361.1 (Amycolatopsisorientalis) | 5 / 12 | ILE A 317ILE A 335ILE A 216VAL A 203HIS A 161 | NoneHHH A4114 (-4.3A)NoneNone CO A4113 ( 3.3A) | 1.04A | 2qo5A-2r5vA:undetectable | 2qo5A-2r5vA:16.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDING GLOBULIN) |
2xgy | RELIK CAPSIDN-TERMINAL DOMAIN (Oryctolaguscuniculus) | 5 / 12 | VAL A 128PHE A 47ILE A 52ASN A 53PHE A 40 | NoneNoneNoneGOL A1138 (-3.7A)None | 1.33A | 2vdyA-2xgyA:undetectable | 2vdyA-2xgyA:16.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VUF_A_FUAA2002_1 (SERUM ALBUMIN) |
5wm9 | RV0078 (Mycobacteriumtuberculosis) | 4 / 9 | ILE A 113PHE A 62VAL A 66GLU A 67 | ILE A 113 ( 0.7A)PHE A 62 ( 1.3A)VAL A 66 ( 0.6A)GLU A 67 ( 0.6A) | 0.82A | 2vufA-5wm9A:4.0 | 2vufA-5wm9A:8.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WSC_B_PQNB1773_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 8 / 10 | TRP A 55MET A 691PHE A 692SER A 695ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.82A | 2wscB-4rkuA:12.6 | 2wscB-4rkuA:45.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WSE_B_PQNB1774_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 8 / 10 | TRP A 55MET A 691PHE A 692SER A 695ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.82A | 2wseB-4rkuA:12.7 | 2wseB-4rkuA:45.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X1L_A_ADNA601_1 (METHIONYL-TRNASYNTHETASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 11 | ALA A 40ALA A 108HIS A 55ILE A 25TRP A 120 | NoneNone MN A1132 (-3.4A)NoneNone | 1.17A | 2x1lA-4bifA:undetectable | 2x1lA-4bifA:15.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAD_E_GCSE710_1 (N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASETEICOPLANIN) |
6fos | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Cyanidioschyzonmerolae) | 4 / 8 | HIS A 605ILE A 522HIS A 532ASP A 528 | CLA A1135 (-4.3A)CLA A1135 ( 4.9A)CLA A1135 (-4.3A)None | 0.98A | 2xadA-6fosA:undetectable | 2xadA-6fosA:11.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAD_F_GCSF710_1 (N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASETEICOPLANIN) |
6fos | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Cyanidioschyzonmerolae) | 4 / 8 | HIS A 605ILE A 522HIS A 532ASP A 528 | CLA A1135 (-4.3A)CLA A1135 ( 4.9A)CLA A1135 (-4.3A)None | 1.00A | 2xadB-6fosA:undetectable | 2xadB-6fosA:11.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAD_G_GCSG710_1 (N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASETEICOPLANIN) |
6fos | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Cyanidioschyzonmerolae) | 4 / 8 | HIS A 605ILE A 522HIS A 532ASP A 528 | CLA A1135 (-4.3A)CLA A1135 ( 4.9A)CLA A1135 (-4.3A)None | 1.00A | 2xadC-6fosA:undetectable | 2xadC-6fosA:11.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAD_H_GCSH710_1 (N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASETEICOPLANIN) |
6fos | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Cyanidioschyzonmerolae) | 4 / 8 | HIS A 605ILE A 522HIS A 532ASP A 528 | CLA A1135 (-4.3A)CLA A1135 ( 4.9A)CLA A1135 (-4.3A)None | 0.97A | 2xadD-6fosA:undetectable | 2xadD-6fosA:11.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XKW_B_P1BB1475_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2r5v | PCZA361.1 (Amycolatopsisorientalis) | 5 / 12 | ILE A 192HIS A 241LEU A 231ILE A 216MET A 199 | None CO A4113 ( 3.4A)NoneNoneNone | 1.05A | 2xkwB-2r5vA:undetectable | 2xkwB-2r5vA:21.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y05_A_RALA802_1 (PROSTAGLANDINREDUCTASE 1) |
2ixq | PROTEIN AFAD (Escherichiacoli) | 4 / 7 | VAL A 113GLY A 68VAL A 65ASP A 70 | VAL A 113 ( 0.5A)GLY A 68 ( 0.0A)VAL A 65 ( 0.5A)ASP A 70 ( 0.4A) | 0.85A | 2y05A-2ixqA:undetectable2y05B-2ixqA:undetectable | 2y05A-2ixqA:17.592y05B-2ixqA:17.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZB8_A_IMNA800_1 (PROSTAGLANDINREDUCTASE 2) |
3umm | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE (Salmonellaenterica) | 5 / 9 | THR A1175PHE A1287TYR A1222VAL A1134LEU A1132 | NoneNoneNoneCYG A1135 ( 2.9A)None | 1.41A | 2zb8A-3ummA:0.9 | 2zb8A-3ummA:14.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A8I_A_C2FA401_0 (AMINOMETHYLTRANSFERASE) |
1wsv | AMINOMETHYLTRANSFERASE (Homosapiens) | 6 / 12 | MET A 56ASP A 101TYR A 113VAL A 115ASN A 117ARG A 233 | MET A 56 (-0.0A)ASP A 101 (-0.6A)TYR A 113 ( 1.3A)VAL A 115 (-0.6A)ASN A 117 (-0.6A)ARG A 233 (-0.6A) | 1.11A | 3a8iA-1wsvA:46.8 | 3a8iA-1wsvA:33.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A8I_B_C2FB401_0 (AMINOMETHYLTRANSFERASE) |
1wsv | AMINOMETHYLTRANSFERASE (Homosapiens) | 6 / 12 | MET A 56ASP A 101TYR A 113VAL A 115ASN A 117ARG A 233 | MET A 56 (-0.0A)ASP A 101 (-0.6A)TYR A 113 ( 1.3A)VAL A 115 (-0.6A)ASN A 117 (-0.6A)ARG A 233 (-0.6A) | 1.12A | 3a8iB-1wsvA:46.2 | 3a8iB-1wsvA:33.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A8I_B_C2FB401_0 (AMINOMETHYLTRANSFERASE) |
2wsh | ENDONUCLEASE II (EscherichiavirusT4) | 5 / 12 | TYR A 37ILE A 39VAL A 46ASN A 130PHE A 92 | PO4 A1133 (-4.7A)NoneNoneNoneNone | 1.31A | 3a8iB-2wshA:undetectable | 3a8iB-2wshA:18.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A8I_C_C2FC401_0 (AMINOMETHYLTRANSFERASE) |
1wsv | AMINOMETHYLTRANSFERASE (Homosapiens) | 6 / 12 | MET A 56TYR A 113VAL A 115ASN A 117TYR A 197ARG A 233 | MET A 56 (-0.0A)TYR A 113 ( 1.3A)VAL A 115 (-0.6A)ASN A 117 (-0.6A)TYR A 197 (-1.3A)ARG A 233 (-0.6A) | 1.16A | 3a8iC-1wsvA:46.4 | 3a8iC-1wsvA:33.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A8I_D_C2FD401_0 (AMINOMETHYLTRANSFERASE) |
1wsv | AMINOMETHYLTRANSFERASE (Homosapiens) | 7 / 12 | MET A 56ASP A 101TYR A 113VAL A 115ASN A 117TYR A 197ARG A 233 | MET A 56 (-0.0A)ASP A 101 (-0.6A)TYR A 113 ( 1.3A)VAL A 115 (-0.6A)ASN A 117 (-0.6A)TYR A 197 (-1.3A)ARG A 233 (-0.6A) | 1.12A | 3a8iD-1wsvA:46.3 | 3a8iD-1wsvA:33.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG1_B_CHDB1085_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 2CYTOCHROME C OXIDASESUBUNIT 6A2) |
2nvv | ACETYL-COAHYDROLASE/TRANSFERASE FAMILY PROTEIN (Porphyromonasgingivalis) | 5 / 11 | GLY A 143THR A 63ARG A 113PHE A 58GLY A 22 | GLY A 143 ( 0.0A)THR A 63 ( 0.8A)ARG A 113 ( 0.6A)PHE A 58 ( 1.3A)GLY A 22 ( 0.0A) | 0.95A | 3ag1A-2nvvA:0.03ag1B-2nvvA:0.03ag1T-2nvvA:0.0 | 3ag1A-2nvvA:22.393ag1B-2nvvA:18.903ag1T-2nvvA:10.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG4_A_CUA517_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 3 / 3 | HIS A 96HIS A 53HIS A 94 | MN A1132 (-3.4A) MN A1132 (-3.3A) MN A1132 (-3.6A) | 0.73A | 3ag4A-4bifA:undetectable | 3ag4A-4bifA:14.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG4_N_CUN517_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 3 / 3 | HIS A 96HIS A 53HIS A 94 | MN A1132 (-3.4A) MN A1132 (-3.3A) MN A1132 (-3.6A) | 0.76A | 3ag4N-4bifA:undetectable | 3ag4N-4bifA:14.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ARR_A_PNXA607_1 (CHITINASE A) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 4 / 7 | VAL A 81SER A 83HIS A 94THR A 75 | NoneNoneCSO A 63 ( 4.8A)PLM A1136 ( 4.9A) | 0.79A | 3arrA-1o8vA:undetectable | 3arrA-1o8vA:11.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ARR_A_PNXA607_1 (CHITINASE A) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 4 / 7 | VAL A 81SER A 83HIS A 94THR A 75 | NoneNoneNoneEDO A1134 ( 4.9A) | 0.56A | 3arrA-4a60A:undetectable | 3arrA-4a60A:14.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B0W_A_DGXA1_1 (NUCLEAR RECEPTORROR-GAMMA) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 12 | ALA A 117ALA A 40VAL A 42PHE A 19HIS A 94 | NoneNoneNoneNone MN A1132 (-3.6A) | 1.24A | 3b0wA-4bifA:undetectable | 3b0wA-4bifA:19.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B0W_B_DGXB1_1 (NUCLEAR RECEPTORROR-GAMMA) |
2r5v | PCZA361.1 (Amycolatopsisorientalis) | 5 / 12 | LEU A 52ALA A 243VAL A 75PHE A 119LEU A 166 | None CO A4113 ( 4.4A)NoneNoneNone | 1.34A | 3b0wB-2r5vA:undetectable | 3b0wB-2r5vA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B0W_B_DGXB1_1 (NUCLEAR RECEPTORROR-GAMMA) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 12 | ALA A 117ALA A 40VAL A 42PHE A 19HIS A 94 | NoneNoneNoneNone MN A1132 (-3.6A) | 1.24A | 3b0wB-4bifA:undetectable | 3b0wB-4bifA:19.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BJW_A_SVRA508_2 (PHOSPHOLIPASE A2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 5 / 9 | GLY A1006LYS A1007PRO A1017LYS A1069ARG A1072 | IPA A1136 (-3.6A)NoneIPA A1136 (-4.4A)NoneNone | 1.29A | 3bjwG-1mc2A:20.0 | 3bjwG-1mc2A:56.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BJW_C_SVRC505_1 (PHOSPHOLIPASE A2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 5 / 10 | GLU A1004GLY A1006PRO A1017LYS A1069ARG A1072 | NoneIPA A1136 (-3.6A)IPA A1136 (-4.4A)NoneNone | 1.15A | 3bjwD-1mc2A:19.9 | 3bjwD-1mc2A:56.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BJW_G_SVRG506_1 (PHOSPHOLIPASE A2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 4 / 8 | GLY A1006LYS A1007PRO A1017ARG A1072 | IPA A1136 (-3.6A)NoneIPA A1136 (-4.4A)None | 0.96A | 3bjwA-1mc2A:20.1 | 3bjwA-1mc2A:56.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BSZ_E_RTLE177_0 (PLASMARETINOL-BINDINGPROTEIN) |
5ab8 | GROUP 1 TRUNCATEDHEMOGLOBIN GLBN (Mycobacteriumtuberculosis) | 5 / 11 | LEU A 122ALA A 64ALA A 65VAL A 126GLN A 58 | NoneACT A1130 ( 4.0A)ACT A1130 ( 4.0A)NoneHEM A 144 ( 3.1A) | 1.27A | 3bszE-5ab8A:undetectable | 3bszE-5ab8A:19.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D1X_A_ROCA201_1 (HIV-1 PROTEASE) |
1gmm | CBM6 (Ruminiclostridiumthermocellum) | 6 / 12 | GLY A 62ALA A 63ASP A 64GLY A 117ILE A 35THR A 85 | NoneNoneNoneNone NA A1131 (-4.1A)None | 1.47A | 3d1xA-1gmmA:undetectable | 3d1xA-1gmmA:20.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D91_A_REMA350_1 (RENIN) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 5 / 12 | GLN A 490GLY A 640SER A 646ASP A 623HIS A 615 | NoneNoneNoneNoneCLA A1135 (-3.7A) | 1.28A | 3d91A-4rkuA:undetectable | 3d91A-4rkuA:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EKX_B_1UNB201_1 (PROTEASE) |
1gmm | CBM6 (Ruminiclostridiumthermocellum) | 6 / 11 | GLY A 62ALA A 63ASP A 64GLY A 117ILE A 35THR A 85 | NoneNoneNoneNone NA A1131 (-4.1A)None | 1.47A | 3ekxA-1gmmA:undetectable | 3ekxA-1gmmA:18.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EL5_B_1UNB201_2 (PROTEASE) |
1gmm | CBM6 (Ruminiclostridiumthermocellum) | 6 / 12 | GLY A 62ALA A 63ASP A 64GLY A 117ILE A 35THR A 85 | NoneNoneNoneNone NA A1131 (-4.1A)None | 1.47A | 3el5B-1gmmA:undetectable | 3el5B-1gmmA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ETE_F_H3PF552_1 (GLUTAMATEDEHYDROGENASE) |
4cx9 | CYTOCHROME C, CLASSII (Shewanellafrigidimarina) | 4 / 7 | ILE A 60LYS A 65ILE A 9TYR A 11 | SO4 A1132 ( 3.9A)NoneHEC A1129 ( 4.7A)None | 1.16A | 3eteD-4cx9A:undetectable3eteF-4cx9A:undetectable | 3eteD-4cx9A:14.463eteF-4cx9A:14.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FL9_C_TOPC200_1 (DIHYDROFOLATEREDUCTASE (DHFR)) |
5nbs | BETA-GLUCOSIDASE (Neurosporacrassa) | 5 / 11 | ALA A 563LEU A 407ILE A 578LEU A 461THR A 562 | NoneNoneNoneNoneNAG A1130 ( 4.9A) | 1.25A | 3fl9C-5nbsA:undetectable | 3fl9C-5nbsA:17.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FL9_H_TOPH200_1 (DIHYDROFOLATEREDUCTASE (DHFR)) |
5nbs | BETA-GLUCOSIDASE (Neurosporacrassa) | 5 / 9 | ALA A 563LEU A 407ILE A 578LEU A 461THR A 562 | NoneNoneNoneNoneNAG A1130 ( 4.9A) | 1.30A | 3fl9H-5nbsA:undetectable | 3fl9H-5nbsA:17.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G88_A_SAMA303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
1whs | SERINECARBOXYPEPTIDASE II (Triticumaestivum) | 5 / 11 | GLY A 27GLY A 25ASP A 23ARG A 114ALA A 97 | NAG A1133 (-3.3A)NoneNoneNoneNone | 1.10A | 3g88A-1whsA:undetectable | 3g88A-1whsA:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G88_B_SAMB303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
1whs | SERINECARBOXYPEPTIDASE II (Triticumaestivum) | 5 / 11 | GLY A 27GLY A 25ASP A 23ARG A 114ALA A 97 | NAG A1133 (-3.3A)NoneNoneNoneNone | 1.10A | 3g88B-1whsA:undetectable | 3g88B-1whsA:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G89_B_SAMB303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
1whs | SERINECARBOXYPEPTIDASE II (Triticumaestivum) | 5 / 11 | GLY A 27GLY A 25ASP A 23ARG A 114ALA A 97 | NAG A1133 (-3.3A)NoneNoneNoneNone | 1.10A | 3g89B-1whsA:undetectable | 3g89B-1whsA:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G8B_A_SAMA303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
1whs | SERINECARBOXYPEPTIDASE II (Triticumaestivum) | 5 / 12 | GLY A 27GLY A 25ASP A 23ARG A 114ALA A 97 | NAG A1133 (-3.3A)NoneNoneNoneNone | 1.08A | 3g8bA-1whsA:undetectable | 3g8bA-1whsA:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_C_VIAC901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
2r5v | PCZA361.1 (Amycolatopsisorientalis) | 4 / 7 | HIS A 241LEU A 171PHE A 119VAL A 122 | CO A4113 ( 3.4A)NoneNoneNone | 1.08A | 3jwqC-2r5vA:undetectable | 3jwqC-2r5vA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K9F_H_LFXH0_1 (DNA TOPOISOMERASE 4SUBUNIT ADNA TOPOISOMERASE 4SUBUNIT B) |
3cbt | PHOSPHATASE SC4828 (Streptomycescoelicolor) | 4 / 6 | ARG A 110GLY A 112GLU A 197GLU A 113 | ARG A 110 (-0.6A)GLY A 112 ( 0.0A)GLU A 197 ( 0.6A)GLU A 113 (-0.5A) | 1.12A | 3k9fA-3cbtA:undetectable3k9fB-3cbtA:undetectable3k9fD-3cbtA:undetectable | 3k9fA-3cbtA:17.643k9fB-3cbtA:17.643k9fD-3cbtA:18.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEE_B_30BB500_2 (GENOME POLYPROTEIN) |
3o52 | GDP-MANNOSEPYROPHOSPHATASE NUDK (Escherichiacoli) | 3 / 3 | PHE A 160TYR A 183LEU A 156 | None NA A7113 (-3.9A)None | 0.76A | 3keeB-3o52A:undetectable | 3keeB-3o52A:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEE_D_30BD500_2 (GENOME POLYPROTEIN) |
3o52 | GDP-MANNOSEPYROPHOSPHATASE NUDK (Escherichiacoli) | 4 / 4 | PHE A 160TYR A 183VAL A 155LEU A 156 | None NA A7113 (-3.9A)NoneNone | 1.02A | 3keeD-3o52A:undetectable | 3keeD-3o52A:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KK6_B_CELB1701_2 (PROSTAGLANDIN G/HSYNTHASE 1) |
1wqa | PHOSPHO-SUGAR MUTASE (Pyrococcushorikoshii) | 4 / 6 | VAL A 83ILE A 18ALA A 96LEU A 113 | VAL A 83 ( 0.6A)ILE A 18 ( 0.7A)ALA A 96 ( 0.0A)LEU A 113 ( 0.6A) | 0.84A | 3kk6B-1wqaA:undetectable | 3kk6B-1wqaA:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KP5_A_KANA2001_1 (TRANSCRIPTIONALREGULATOR TCAR) |
3gnr | OS03G0212800 PROTEIN (Oryzasativa) | 5 / 11 | VAL A 128ALA A 118GLU A 73ASN A 113ARG A 169 | VAL A 128 ( 0.6A)ALA A 118 ( 0.0A)GLU A 73 ( 0.5A)ASN A 113 ( 0.6A)ARG A 169 ( 0.6A) | 1.41A | 3kp5A-3gnrA:undetectable | 3kp5A-3gnrA:16.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LW5_A_PQNA5001_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 6 / 9 | TRP A 55MET A 691PHE A 692SER A 695LEU A 725GLY A 730 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)PQN A5001 ( 3.7A)PQN A5001 ( 4.0A) | 1.38A | 3lw5A-4rkuA:42.7 | 3lw5A-4rkuA:99.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LW5_B_PQNB5002_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 6 / 10 | ILE B 21MET B 662PHE B 663SER B 666LEU B 700ALA B 705 | CLA A1131 ( 4.4A)CLA B9023 ( 3.3A)PQN B5002 ( 4.3A)PQN B5002 (-3.2A)PQN B5002 (-3.7A)PQN B5002 (-3.4A) | 1.48A | 3lw5B-4rkuB:15.5 | 3lw5B-4rkuB:98.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MDV_A_CL6A506_1 (CHOLESTEROL24-HYDROXYLASE) |
5nbs | BETA-GLUCOSIDASE (Neurosporacrassa) | 5 / 9 | VAL A 533ILE A 496ALA A 495ALA A 563THR A 562 | NoneNoneNoneNoneNAG A1130 ( 4.9A) | 1.12A | 3mdvA-5nbsA:undetectable | 3mdvA-5nbsA:11.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OCT_A_1N1A663_2 (TYROSINE-PROTEINKINASE BTK) |
2xy3 | SPBC2PROPHAGE-DERIVEDDEOXYURIDINE5'-TRIPHOSPHATENUCLEOTIDOHYDROLASEYOSS (Bacillussubtilis) | 4 / 5 | PHE A 91ILE A 108ASN A 87PHE A 92 | DUP A1130 (-3.3A)NoneNoneNone | 1.35A | 3octA-2xy3A:undetectable | 3octA-2xy3A:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OHT_A_1N1A2000_1 (P38A) |
2byc | BLUE-LIGHT RECEPTOROF THE BLUF-FAMILY (Rhodobactersphaeroides) | 5 / 12 | ILE A 76ARG A 65ILE A 67ALA A 78TYR A 9 | NoneNoneFMN A1137 ( 4.2A)NoneNone | 1.14A | 3ohtA-2bycA:undetectable3ohtB-2bycA:undetectable | 3ohtA-2bycA:19.173ohtB-2bycA:19.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OKX_B_SAMB201_1 (YAEB-LIKE PROTEINRPA0152) |
3p8c | NCK-ASSOCIATEDPROTEIN 1 (Homosapiens) | 5 / 12 | LEU B 596ARG B 594THR B 701CYH B 599LEU B 598 | GOL B1132 ( 4.3A)NoneNoneNoneNone | 1.30A | 3okxB-3p8cB:undetectable | 3okxB-3p8cB:10.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_B_ESTB600_1 (ESTROGEN RECEPTORBETA) |
3wd7 | TYPE III POLYKETIDESYNTHASES ACRIDONESYNTHASE (Citrusxmicrocarpa) | 5 / 12 | LEU A 222ALA A 113GLU A 116ARG A 234LEU A 187 | LEU A 222 ( 0.6A)ALA A 113 ( 0.0A)GLU A 116 ( 0.5A)ARG A 234 ( 0.6A)LEU A 187 ( 0.5A) | 1.17A | 3olsB-3wd7A:undetectable | 3olsB-3wd7A:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OU7_B_SAMB300_1 (SAM-DEPENDENTMETHYLTRANSFERASE) |
1jzn | GALACTOSE-SPECIFICLECTIN (Crotalusatrox) | 3 / 3 | TYR A 100ASP A 120ASP A 93 | GAL A 137 ( 4.1A) CA A1138 ( 3.0A)None | 0.87A | 3ou7B-1jznA:undetectable | 3ou7B-1jznA:19.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 10 / 12 | PHE A 16MET A 20VAL A 25PRO A 38ASP A 77ARG A 79ILE A 105ARG A 107ARG A 127TYR A 129 | PLM A1136 (-4.7A)PLM A1136 (-3.5A)NoneNonePLM A1136 (-3.8A)PLM A1136 (-4.6A)NonePLM A1136 (-3.9A)PLM A1136 (-4.4A)PLM A1136 (-4.6A) | 0.55A | 3p6gA-1o8vA:23.7 | 3p6gA-1o8vA:41.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 7 / 12 | PHE A 16MET A 20VAL A 25PRO A 38CYH A 125ARG A 127TYR A 129 | PLM A1136 (-4.7A)PLM A1136 (-3.5A)NoneNoneNonePLM A1136 (-4.4A)PLM A1136 (-4.6A) | 1.24A | 3p6gA-1o8vA:23.7 | 3p6gA-1o8vA:41.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 10 / 12 | MET A 21VAL A 26PRO A 39ASP A 77ARG A 79ARG A 107VAL A 116CYH A 118ARG A 127TYR A 129 | EDO A1134 (-4.5A)NoneNoneEDO A1134 (-3.7A)EDO A1134 ( 4.9A)NoneNoneNoneNoneNone | 0.78A | 3p6gA-4a60A:24.2 | 3p6gA-4a60A:56.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 10 / 12 | MET A 21VAL A 26PRO A 39ASP A 77ARG A 79ILE A 105VAL A 116CYH A 118ARG A 127TYR A 129 | EDO A1134 (-4.5A)NoneNoneEDO A1134 (-3.7A)EDO A1134 ( 4.9A)NoneNoneNoneNoneNone | 0.71A | 3p6gA-4a60A:24.2 | 3p6gA-4a60A:56.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 9 / 12 | PHE A 17MET A 21VAL A 26PRO A 39ASP A 77ARG A 79ARG A 107ARG A 127TYR A 129 | NoneEDO A1134 (-4.5A)NoneNoneEDO A1134 (-3.7A)EDO A1134 ( 4.9A)NoneNoneNone | 0.86A | 3p6gA-4a60A:24.2 | 3p6gA-4a60A:56.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 9 / 12 | PHE A 17MET A 21VAL A 26PRO A 39ASP A 77ARG A 79ILE A 105ARG A 127TYR A 129 | NoneEDO A1134 (-4.5A)NoneNoneEDO A1134 (-3.7A)EDO A1134 ( 4.9A)NoneNoneNone | 0.83A | 3p6gA-4a60A:24.2 | 3p6gA-4a60A:56.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 12 / 12 | PHE A 19MET A 23VAL A 28PRO A 41ASP A 79ARG A 81ILE A 107ARG A 109VAL A 118CYH A 120ARG A 129TYR A 131 | NoneA9M A1136 (-3.7A)NoneA9M A1136 ( 4.7A)A9M A1136 (-4.0A)NoneA9M A1136 (-4.4A)NoneNoneA9M A1136 ( 3.8A)A9M A1136 (-4.3A)A9M A1136 (-4.8A) | 0.65A | 3p6gA-4azpA:24.1 | 3p6gA-4azpA:50.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 8 / 12 | PHE A 19MET A 23VAL A 28PRO A 41ASP A 79CYH A 127ARG A 129TYR A 131 | NoneA9M A1136 (-3.7A)NoneA9M A1136 ( 4.7A)A9M A1136 (-4.0A)NoneA9M A1136 (-4.3A)A9M A1136 (-4.8A) | 1.22A | 3p6gA-4azpA:24.1 | 3p6gA-4azpA:50.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6H_A_IBPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 6 / 7 | PHE A 16MET A 20ASP A 77ILE A 105ARG A 127TYR A 129 | PLM A1136 (-4.7A)PLM A1136 (-3.5A)PLM A1136 (-3.8A)NonePLM A1136 (-4.4A)PLM A1136 (-4.6A) | 0.58A | 3p6hA-1o8vA:23.7 | 3p6hA-1o8vA:41.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6H_A_IBPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 6 / 7 | MET A 21ASP A 77ILE A 105VAL A 116ARG A 127TYR A 129 | EDO A1134 (-4.5A)EDO A1134 (-3.7A)NoneNoneNoneNone | 0.56A | 3p6hA-4a60A:24.1 | 3p6hA-4a60A:56.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6H_A_IBPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 7 | PHE A 17MET A 21ASP A 77ARG A 127TYR A 129 | NoneEDO A1134 (-4.5A)EDO A1134 (-3.7A)NoneNone | 0.83A | 3p6hA-4a60A:24.1 | 3p6hA-4a60A:56.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6H_A_IBPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 7 / 7 | PHE A 19MET A 23ASP A 79ILE A 107VAL A 118ARG A 129TYR A 131 | NoneA9M A1136 (-3.7A)A9M A1136 (-4.0A)A9M A1136 (-4.4A)NoneA9M A1136 (-4.3A)A9M A1136 (-4.8A) | 0.44A | 3p6hA-4azpA:24.1 | 3p6hA-4azpA:50.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PCQ_B_PQNB842_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 9 / 11 | TRP A 55MET A 691PHE A 692SER A 695ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.59A | 3pcqB-4rkuA:33.5 | 3pcqB-4rkuA:45.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QEO_A_LLTA261_1 (DEOXYCYTIDINE KINASE) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 10 | GLU A 73LEU A 24MET A 21TYR A 20GLN A 59 | NoneNoneEDO A1134 (-4.5A)NoneEDO A1134 ( 3.9A) | 1.18A | 3qeoA-4a60A:0.0 | 3qeoA-4a60A:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S3O_A_DLUA399_1 (PFV INTEGRASE) |
2ktq | PROTEIN (LARGEFRAGMENT OF DNAPOLYMERASE I) (Thermusaquaticus) | 4 / 7 | ASP A 610ASP A 785GLN A 582GLU A 786 | MG A 901 (-4.3A)DCT A 113 ( 2.4A)NoneNone | 1.26A | 3s3oA-2ktqA:undetectable | 3s3oA-2ktqA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S56_A_ROCA201_2 (PROTEASE) |
3p8c | NCK-ASSOCIATEDPROTEIN 1 (Homosapiens) | 5 / 9 | ARG B 343LEU B 408ILE B 541ILE B 405ILE B 409 | CL B1131 (-3.8A)NoneNoneNoneNone | 1.04A | 3s56B-3p8cB:undetectable | 3s56B-3p8cB:6.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SI7_B_ACTB4_0 (CYSTIC FIBROSISTRANSMEMBRANECONDUCTANCEREGULATOR) |
1zu4 | FTSY (Mycoplasmamycoides) | 3 / 3 | GLY A 206GLY A 208THR A 210 | SO4 A1130 (-3.8A)SO4 A1130 (-3.7A)SO4 A1130 (-3.2A) | 0.37A | 3si7B-1zu4A:undetectable | 3si7B-1zu4A:23.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SO9_A_017A100_1 (HIV-1 PROTEASE) |
1gmm | CBM6 (Ruminiclostridiumthermocellum) | 5 / 8 | GLY A 62ALA A 63ASP A 64GLY A 117ILE A 35 | NoneNoneNoneNone NA A1131 (-4.1A) | 1.37A | 3so9A-1gmmA:undetectable | 3so9A-1gmmA:19.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SUE_B_SUEB1201_2 (NS3 PROTEASE, NS4APROTEIN) |
3o52 | GDP-MANNOSEPYROPHOSPHATASE NUDK (Escherichiacoli) | 3 / 3 | PHE A 160TYR A 183LEU A 156 | None NA A7113 (-3.9A)None | 0.78A | 3sueB-3o52A:undetectable | 3sueB-3o52A:20.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SUG_A_SUEA1201_1 (NS3 PROTEASE, NS4APROTEIN) |
4chg | PROBABLERIBONUCLEASE VAPC15 (Mycobacteriumtuberculosis) | 5 / 12 | VAL A 3ARG A 92GLY A 125ALA A 119ASP A 116 | NoneNoneNoneNone MN A1133 (-3.0A) | 1.07A | 3sugA-4chgA:undetectable | 3sugA-4chgA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UZZ_B_ASDB501_1 (3-OXO-5-BETA-STEROID4-DEHYDROGENASE) |
3c2c | CYTOCHROME C2 (Rhodospirillumrubrum) | 4 / 8 | TYR A 52TYR A 48HIS A 42LEU A 67 | HEM A 113 (-4.2A)HEM A 113 (-4.2A)HEM A 113 (-3.3A)None | 1.26A | 3uzzB-3c2cA:undetectable | 3uzzB-3c2cA:15.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V4T_A_ACTA505_0 (UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE) |
4chg | PROBABLERIBONUCLEASE VAPC15ANTITOXIN VAPB15 (Mycobacteriumtuberculosis;Mycobacteriumtuberculosis) | 3 / 3 | THR A 5ASN G 63GLU A 42 | None MG A1134 ( 4.1A) MG A1134 ( 3.8A) | 0.71A | 3v4tA-4chgA:undetectable3v4tC-4chgA:undetectable | 3v4tA-4chgA:18.893v4tC-4chgA:18.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V4T_C_ACTC502_0 (UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE) |
2cjt | UNC-13 HOMOLOG A (Rattusnorvegicus) | 3 / 3 | PRO A 93ASP A 124GLU A 95 | EDO A1132 (-3.9A)EDO A1132 ( 3.4A)EDO A1133 ( 4.5A) | 0.67A | 3v4tC-2cjtA:undetectable | 3v4tC-2cjtA:16.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VXI_A_ASCA502_0 (DYP) |
2w47 | LIPOLYTIC ENZYME,G-D-S-L (Ruminiclostridiumthermocellum) | 4 / 5 | ALA A 66ASN A 62ARG A 68PRO A 69 | NoneNoneUNF A1138 (-2.9A)None | 1.37A | 3vxiA-2w47A:undetectable | 3vxiA-2w47A:14.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_A_W9TA1001_1 (HEMOLYTIC LECTINCEL-III) |
4nen | INTEGRIN ALPHA-X (Homosapiens) | 4 / 5 | ASP A 515VAL A 540GLY A 539ASP A 511 | CA A1113 (-2.6A)NoneNone CA A1113 (-3.2A) | 1.18A | 3w9tA-4nenA:undetectable | 3w9tA-4nenA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_B_W9TB503_1 (HEMOLYTIC LECTINCEL-III) |
4nen | INTEGRIN ALPHA-X (Homosapiens) | 4 / 5 | ASP A 515VAL A 540GLY A 539ASP A 511 | CA A1113 (-2.6A)NoneNone CA A1113 (-3.2A) | 1.18A | 3w9tB-4nenA:undetectable | 3w9tB-4nenA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_C_W9TC1001_1 (HEMOLYTIC LECTINCEL-III) |
4nen | INTEGRIN ALPHA-X (Homosapiens) | 4 / 5 | ASP A 515VAL A 540GLY A 539ASP A 511 | CA A1113 (-2.6A)NoneNone CA A1113 (-3.2A) | 1.18A | 3w9tC-4nenA:undetectable | 3w9tC-4nenA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_D_W9TD502_1 (HEMOLYTIC LECTINCEL-III) |
4nen | INTEGRIN ALPHA-X (Homosapiens) | 4 / 5 | ASP A 515VAL A 540GLY A 539ASP A 511 | CA A1113 (-2.6A)NoneNone CA A1113 (-3.2A) | 1.18A | 3w9tD-4nenA:undetectable | 3w9tD-4nenA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_E_W9TE504_1 (HEMOLYTIC LECTINCEL-III) |
4nen | INTEGRIN ALPHA-X (Homosapiens) | 4 / 5 | ASP A 515VAL A 540GLY A 539ASP A 511 | CA A1113 (-2.6A)NoneNone CA A1113 (-3.2A) | 1.18A | 3w9tE-4nenA:undetectable | 3w9tE-4nenA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_E_W9TE506_1 (HEMOLYTIC LECTINCEL-III) |
2cjt | UNC-13 HOMOLOG A (Rattusnorvegicus) | 4 / 6 | THR A 22ASN A 66GLY A 68ASP A 72 | NoneFMT A1138 (-3.8A)FMT A1137 ( 3.1A)EDO A1134 (-2.9A) | 1.18A | 3w9tE-2cjtA:undetectable | 3w9tE-2cjtA:14.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_F_W9TF504_1 (HEMOLYTIC LECTINCEL-III) |
4nen | INTEGRIN ALPHA-X (Homosapiens) | 4 / 5 | ASP A 515VAL A 540GLY A 539ASP A 511 | CA A1113 (-2.6A)NoneNone CA A1113 (-3.2A) | 1.18A | 3w9tF-4nenA:undetectable | 3w9tF-4nenA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_G_W9TG504_1 (HEMOLYTIC LECTINCEL-III) |
4nen | INTEGRIN ALPHA-X (Homosapiens) | 4 / 5 | ASP A 515VAL A 540GLY A 539ASP A 511 | CA A1113 (-2.6A)NoneNone CA A1113 (-3.2A) | 1.19A | 3w9tG-4nenA:undetectable | 3w9tG-4nenA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN) |
5gru | DIABODY PROTEIN (Homosapiens) | 4 / 5 | GLY H 99TYR H 102TYR H 100GLU H 113 | GLY H 99 ( 0.0A)TYR H 102 ( 1.3A)TYR H 100 ( 1.3A)GLU H 113 ( 0.6A) | 1.20A | 4ae1B-5gruH:3.9 | 4ae1B-5gruH:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AZV_A_SAMA1474_1 (WBDD) |
6b0n | ENVELOPEGLYCOPROTEIN GP140 (Humanimmunodeficiencyvirus1) | 4 / 6 | ARG G 151ASP G 180GLN G 422GLU G 370 | NAG G1133 ( 4.0A)NoneNoneNone | 0.96A | 4azvA-6b0nG:undetectable | 4azvA-6b0nG:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B53_B_ACTB1445_0 (IG GAMMA-4 CHAIN CREGION) |
2cjt | UNC-13 HOMOLOG A (Rattusnorvegicus) | 3 / 3 | GLU A 90GLY A 92SER A 88 | NoneEDO A1132 (-3.5A)None | 0.68A | 4b53B-2cjtA:2.9 | 4b53B-2cjtA:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BLV_A_SAMA1281_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J) |
2cbm | NEOCARZINOSTATIN (Streptomycescarzinostaticus) | 5 / 12 | LEU A 26GLY A 102LEU A 97ASP A 99GLY A 107 | NoneMES A1113 (-4.5A)NoneNoneMES A1113 ( 4.2A) | 1.14A | 4blvA-2cbmA:undetectable | 4blvA-2cbmA:19.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4C1D_A_X8ZA350_1 (BETA-LACTAMASE CLASSB VIM-2) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 6 / 9 | HIS A 101ASP A 103HIS A 162CYH A 181ASN A 193HIS A 223 | ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 (-4.1A)113 A2002 ( 3.6A) | 0.37A | 4c1dA-1hlkA:32.5 | 4c1dA-1hlkA:32.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4C1D_B_X8ZB350_1 (BETA-LACTAMASE CLASSB VIM-2) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 7 / 10 | HIS A 99HIS A 101ASP A 103HIS A 162CYH A 181ASN A 193HIS A 223 | ZN A1001 (-3.4A) ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 (-4.1A)113 A2002 ( 3.6A) | 0.40A | 4c1dB-1hlkA:32.6 | 4c1dB-1hlkA:32.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4C1F_A_X8ZA300_1 (BETA-LACTAMASE IMP-1) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 7 / 11 | TRP A 49HIS A 99HIS A 101ASP A 103HIS A 162CYH A 181HIS A 223 | 113 A2002 (-3.9A) ZN A1001 (-3.4A) ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 ( 3.6A) | 0.56A | 4c1fA-1hlkA:15.24c1fB-1hlkA:32.3 | 4c1fA-1hlkA:35.654c1fB-1hlkA:35.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4C1H_A_X8ZA305_1 (BETA-LACTAMASE 2) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 7 / 9 | HIS A 99HIS A 101ASP A 103HIS A 162CYH A 181GLY A 192HIS A 223 | ZN A1001 (-3.4A) ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 ( 3.8A)113 A2002 ( 3.6A) | 0.50A | 4c1hA-1hlkA:35.2 | 4c1hA-1hlkA:34.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C5N_C_PXLC300_1 (PHOSPHOMETHYLPYRIMIDINE KINASE) |
5w0a | GLUCANASE (Trichodermaharzianum) | 4 / 8 | GLY A 113ASP A 117GLY A 116VAL A 33 | GLY A 113 ( 0.0A)ASP A 117 ( 0.5A)GLY A 116 ( 0.0A)VAL A 33 ( 0.6A) | 0.78A | 4c5nC-5w0aA:undetectable | 4c5nC-5w0aA:14.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D7B_B_TCWB1126_1 (TRANSTHYRETIN) |
3gwm | HOLO-[ACYL-CARRIER-PROTEIN] SYNTHASE (Mycolicibacteriumsmegmatis) | 4 / 7 | THR A 120ALA A 122SER A 113THR A 115 | THR A 120 ( 0.8A)ALA A 122 ( 0.0A)SER A 113 ( 0.0A)THR A 115 (-0.8A) | 0.82A | 4d7bA-3gwmA:undetectable | 4d7bA-3gwmA:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1G_A_LNLA701_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
2ooc | HISTIDINEPHOSPHOTRANSFERASE (Caulobactervibrioides) | 4 / 5 | ARG A 76VAL A 87LEU A 84SER A 83 | NoneNonePG4 A 113 ( 4.7A)GOL A 114 (-3.8A) | 1.34A | 4e1gA-2oocA:undetectable | 4e1gA-2oocA:10.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EXS_A_X8ZA301_1 (BETA-LACTAMASE NDM-1) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 6 / 9 | VAL A 52HIS A 101ASP A 103HIS A 162CYH A 181HIS A 223 | 113 A2002 ( 4.9A) ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 ( 3.6A) | 0.42A | 4exsA-1hlkA:31.8 | 4exsA-1hlkA:27.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EXS_B_X8ZB301_1 (BETA-LACTAMASE NDM-1) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 7 / 8 | VAL A 52HIS A 101ASP A 103HIS A 162CYH A 181ASN A 193HIS A 223 | 113 A2002 ( 4.9A) ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 (-4.1A)113 A2002 ( 3.6A) | 0.55A | 4exsB-1hlkA:32.2 | 4exsB-1hlkA:27.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4F5Z_A_BEZA302_0 (HALOALKANEDEHALOGENASE) |
2r5v | PCZA361.1 (Amycolatopsisorientalis) | 4 / 8 | ASP A 160VAL A 203LEU A 303HIS A 161 | NoneNoneNone CO A4113 ( 3.3A) | 0.97A | 4f5zA-2r5vA:undetectable | 4f5zA-2r5vA:23.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FE1_B_PQNB840_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | MET A 691SER A 695ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A9013 ( 3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.66A | 4fe1B-4rkuA:33.4 | 4fe1B-4rkuA:45.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G0V_A_MIXA1301_1 (DNA TOPOISOMERASE2-BETA) |
1uzd | RIBULOSEBISPHOSPHATECARBOXYLASE SMALLCHAIN 1, RIBULOSEBISPHOSPHATECARBOXYLASE SMALLCHAIN 2 (Chlamydomonasreinhardtii;Spinaciaoleracea) | 4 / 7 | ARG C 78GLY C 76ILE C 39ASN C 106 | NoneEDO C1136 (-3.4A)EDO C1136 (-4.3A)None | 1.10A | 4g0vA-1uzdC:undetectable | 4g0vA-1uzdC:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJI_H_BEZH501_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN YIBF) |
2xgy | RELIK CAPSIDN-TERMINAL DOMAIN (Oryctolaguscuniculus) | 4 / 7 | ASN A 57VAL A 128TYR A 124ARG A 103 | GOL A1138 (-4.0A)NoneNoneGOL A1138 (-4.0A) | 0.91A | 4ijiH-2xgyA:undetectable | 4ijiH-2xgyA:25.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KLR_A_CHDA505_0 (FERROCHELATASE,MITOCHONDRIAL) |
6ezy | - (-) | 4 / 5 | LEU A 110PRO A 109LEU A 113ILE A 179 | LEU A 110 ( 0.6A)PRO A 109 ( 1.1A)LEU A 113 ( 0.6A)ILE A 179 ( 0.7A) | 0.84A | 4klrA-6ezyA:undetectable | 4klrA-6ezyA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KT0_B_PQNB2002_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | TRP A 55MET A 691SER A 695ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.50A | 4kt0B-4rkuA:37.8 | 4kt0B-4rkuA:46.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4L6V_1_PQN12001_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1FUSION PROTEIN OFPHOTOSYSTEM ISUBUNIT III ANDSUBUNIT IX) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 10 / 11 | TRP A 55MET A 691PHE A 692SER A 695GLY A 696ARG A 697TRP A 700ALA A 724LEU A 725GLY A 730 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)PQN A5001 ( 4.1A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A)PQN A5001 ( 4.0A) | 0.32A | 4l6v1-4rkuA:43.34l6v6-4rkuA:2.0 | 4l6v1-4rkuA:81.004l6v6-4rkuA:11.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4L6V_2_PQN22002_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | TRP A 55MET A 691SER A 695ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.59A | 4l6v2-4rkuA:39.9 | 4l6v2-4rkuA:46.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4L6V_A_PQNA2001_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1FUSION PROTEIN OFPHOTOSYSTEM ISUBUNIT III ANDSUBUNIT IX) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 8 / 9 | TRP A 55MET A 691PHE A 692SER A 695TRP A 700ALA A 724LEU A 725GLY A 730 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)PQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A)PQN A5001 ( 4.0A) | 0.28A | 4l6va-4rkuA:43.34l6vf-4rkuA:undetectable | 4l6va-4rkuA:81.004l6vf-4rkuA:11.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4L6V_B_PQNB2002_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | TRP A 55MET A 691SER A 695ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.56A | 4l6vB-4rkuA:34.0 | 4l6vB-4rkuA:46.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LNW_A_T3A502_1 (THYROID HORMONERECEPTOR ALPHA) |
4chg | ANTITOXIN VAPB15PROBABLERIBONUCLEASE VAPC15 (Mycobacteriumtuberculosis) | 4 / 8 | SER A 6GLU G 67VAL A 110THR A 128 | None MN A1133 ( 1.9A)NoneNone | 0.85A | 4lnwA-4chgA:undetectable | 4lnwA-4chgA:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LNX_A_T44A501_1 (THYROID HORMONERECEPTOR ALPHA) |
4chg | ANTITOXIN VAPB15PROBABLERIBONUCLEASE VAPC15 (Mycobacteriumtuberculosis) | 4 / 6 | SER A 6GLU G 67VAL A 110THR A 128 | None MN A1133 ( 1.9A)NoneNone | 0.96A | 4lnxA-4chgA:undetectable | 4lnxA-4chgA:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LUH_A_ACTA608_0 (SERUM ALBUMIN) |
1wly | 2-HALOACRYLATEREDUCTASE (Burkholderiasp.WS) | 4 / 4 | PRO A 113ASP A 115LEU A 116ARG A 87 | PRO A 113 ( 1.1A)ASP A 115 ( 0.5A)LEU A 116 ( 0.6A)ARG A 87 ( 0.6A) | 1.42A | 4luhA-1wlyA:0.0 | 4luhA-1wlyA:19.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MS4_A_2C0A501_1 (GAMMA-AMINOBUTYRICACID TYPE B RECEPTORSUBUNIT 1) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 4 / 8 | SER A 42SER A 54HIS A 223ILE A 46 | NA A2001 ( 4.6A) NA A2001 ( 4.9A)113 A2002 ( 3.6A)113 A2002 (-4.1A) | 1.35A | 4ms4A-1hlkA:undetectable | 4ms4A-1hlkA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MUB_A_OAQA302_0 (SULFOTRANSFERASE) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 5 / 12 | HIS A 545GLY A 366THR A 552MET A 400THR A 369 | CLA A1135 (-3.9A)NoneCLA A1124 (-3.5A)CLA A1124 (-3.6A)CLA A1127 (-3.3A) | 1.33A | 4mubA-4rkuA:undetectable | 4mubA-4rkuA:14.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N16_A_CHDA301_0 (CARBONIC ANHYDRASE 2) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 4 / 8 | GLN A 98PHE A 73THR A 56THR A 63 | NoneNoneA9M A1136 ( 4.3A)None | 0.82A | 4n16A-4azpA:undetectable | 4n16A-4azpA:19.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N49_A_SAMA601_1 (CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1) |
2yil | MICRONEME ANTIGEN L2 (Sarcocystismuris) | 4 / 4 | ASN A 52GLY A 70ASP A 6ASP A 13 | NoneNoneNoneGOL A1137 (-4.1A) | 1.29A | 4n49A-2yilA:undetectable | 4n49A-2yilA:18.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OBW_A_SAMA602_0 (2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOLMETHYLASE,MITOCHONDRIAL) |
4x0o | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 3 PROTEIN 2 (Vibriocholerae) | 5 / 12 | ASN A 110GLY A 312ILE A 190GLY A 216PHE A 214 | NoneSCY A 113 ( 3.1A)NoneNoneNone | 1.20A | 4obwA-4x0oA:undetectable | 4obwA-4x0oA:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OBW_C_SAMC601_0 (2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOLMETHYLASE,MITOCHONDRIAL) |
4x0o | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 3 PROTEIN 2 (Vibriocholerae) | 5 / 12 | ASN A 110GLY A 312ILE A 190GLY A 216PHE A 214 | NoneSCY A 113 ( 3.1A)NoneNoneNone | 1.23A | 4obwC-4x0oA:undetectable | 4obwC-4x0oA:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OKX_A_198A1002_1 (ANDROGEN RECEPTOR) |
5fmt | FLAGELLAR ASSOCIATEDPROTEIN (Chlamydomonasreinhardtii) | 5 / 12 | LEU A 54LEU A 113VAL A 85THR A 48VAL A 18 | NoneNoneSO4 A1131 ( 4.8A)NoneNone | 1.14A | 4okxA-5fmtA:undetectable | 4okxA-5fmtA:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P6S_A_DAHA304_1 (TYROSINASE) |
6fos | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Cyanidioschyzonmerolae) | 4 / 5 | ASN A 455LEU A 451HIS A 454THR A 471 | NoneCLA A1132 (-4.5A)CLA A1132 (-3.6A)None | 1.42A | 4p6sA-6fosA:undetectable | 4p6sA-6fosA:15.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4POO_B_SAMB301_0 (PUTATIVE RNAMETHYLASE) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 5 / 12 | THR A 348GLY A 346HIS A 68ASN A 349SER A 942 | NoneNoneNoneNoneNAG A1132 (-3.6A) | 1.38A | 4pooB-4iugA:undetectable | 4pooB-4iugA:11.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PWJ_B_30ZB201_1 (TRANSTHYRETIN) |
3gwm | HOLO-[ACYL-CARRIER-PROTEIN] SYNTHASE (Mycolicibacteriumsmegmatis) | 4 / 7 | THR A 120ALA A 122SER A 113THR A 115 | THR A 120 ( 0.8A)ALA A 122 ( 0.0A)SER A 113 ( 0.0A)THR A 115 (-0.8A) | 0.79A | 4pwjB-3gwmA:undetectable | 4pwjB-3gwmA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_B_HFGB803_0 (PROLINE--TRNA LIGASE) |
2mcm | MACROMOMYCIN (Streptomycesmacromomyceticus) | 5 / 12 | PRO A 27THR A 26GLU A 103SER A 101GLY A 98 | NoneNoneNoneNoneMRD A 113 ( 4.3A) | 1.28A | 4q15B-2mcmA:undetectable | 4q15B-2mcmA:10.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QZT_A_ACTA202_0 (RETINOL-BINDINGPROTEIN 2) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 4 / 6 | TYR A 20GLU A 73THR A 75GLN A 96 | NoneNoneEDO A1134 ( 4.9A)None | 0.80A | 4qztA-4a60A:19.7 | 4qztA-4a60A:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QZU_C_ACTC202_0 (RETINOL-BINDINGPROTEIN 2) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 4 / 6 | TYR A 20GLU A 73THR A 75GLN A 96 | NoneNoneEDO A1134 ( 4.9A)None | 0.81A | 4qzuC-4a60A:19.9 | 4qzuC-4a60A:30.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RYA_A_MTLA501_1 (ABC TRANSPORTERSUBSTRATE BINDINGPROTEIN (SORBITOL)) |
3kbb | PHOSPHORYLATEDCARBOHYDRATESPHOSPHATASE TM_1254 (Thermotogamaritima) | 3 / 3 | GLU A 113TYR A 19GLU A 47 | GLU A 113 ( 0.6A)TYR A 19 ( 1.3A)GLU A 47 (-0.6A) | 0.82A | 4ryaA-3kbbA:undetectable | 4ryaA-3kbbA:17.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCK_B_SAMB2409_0 (RNA-DIRECTED RNAPOLYMERASE L) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 5 / 12 | GLY A 516GLY A 517SER A 510ALA A 507ALA A 499 | NoneNoneNoneCLA A1133 ( 4.6A)CLA A1133 ( 3.7A) | 1.10A | 4uckB-4rkuA:undetectable | 4uckB-4rkuA:20.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XK8_B_PQNB842_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 8 / 10 | TRP A 55MET A 691SER A 695ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.63A | 4xk8B-4rkuA:38.7 | 4xk8B-4rkuA:45.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y28_B_PQNB5002_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | TRP A 55MET A 691SER A 695ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.54A | 4y28B-4rkuA:34.0 | 4y28B-4rkuA:45.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_B_HFGB802_0 (PROLINE--TRNA LIGASE) |
2mcm | MACROMOMYCIN (Streptomycesmacromomyceticus) | 5 / 12 | PRO A 27THR A 26GLU A 103SER A 101GLY A 98 | NoneNoneNoneNoneMRD A 113 ( 4.3A) | 1.31A | 4ydqB-2mcmA:undetectable | 4ydqB-2mcmA:10.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YV5_A_SVRA205_2 (BASIC PHOSPHOLIPASEA2 HOMOLOG 2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 4 / 6 | LYS A1007ASN A1016PRO A1017ARG A1072 | NoneNoneIPA A1136 (-4.4A)None | 0.67A | 4yv5B-1mc2A:24.2 | 4yv5B-1mc2A:77.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YV5_B_SVRB207_1 (BASIC PHOSPHOLIPASEA2 HOMOLOG 2) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 4 / 6 | LYS A1007ASN A1016PRO A1017ARG A1072 | NoneNoneIPA A1136 (-4.4A)None | 0.63A | 4yv5A-1mc2A:23.9 | 4yv5A-1mc2A:77.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z53_H_TR6H101_1 (DNA TOPOISOMERASE 4SUBUNIT B,DNATOPOISOMERASE 4SUBUNIT AE-SITE DNA) |
4csb | VIRULENCE ASSOCIATEDPROTEIN VAPD (Rhodococcushoagii) | 4 / 7 | GLY A 59ASP A 60GLY A 132GLU A 134 | NoneBOG A1135 (-4.4A)NoneNone | 0.88A | 4z53A-4csbA:undetectable4z53B-4csbA:undetectable | 4z53A-4csbA:10.654z53B-4csbA:10.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZBQ_A_ACTA605_0 (SERUM ALBUMIN) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 4 / 6 | TYR A 96GLY A 136GLU A 198ASN A 199 | GAL A1130 (-4.7A)NoneNoneGAL A1130 (-3.5A) | 1.12A | 4zbqA-4iugA:undetectable | 4zbqA-4iugA:20.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZE2_A_1YNA602_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 4 / 5 | ALA A 570TYR A 571HIS A 432PRO A 509 | SEP A 569 ( 3.7A)NAG A1138 (-4.9A)NoneNone | 1.10A | 4ze2A-4iugA:undetectable | 4ze2A-4iugA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5A5Z_A_WJZA304_0 (BETA-LACTAMASE NDM-1) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 7 / 8 | VAL A 52HIS A 101ASP A 103HIS A 162CYH A 181ASN A 193HIS A 223 | 113 A2002 ( 4.9A) ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 (-4.1A)113 A2002 ( 3.6A) | 0.40A | 5a5zA-1hlkA:32.5 | 5a5zA-1hlkA:29.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5A5Z_C_WJZC304_0 (BETA-LACTAMASE NDM-1) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 5 / 7 | HIS A 162CYH A 181GLY A 192ASN A 193HIS A 223 | ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 ( 3.8A)113 A2002 (-4.1A)113 A2002 ( 3.6A) | 0.50A | 5a5zC-1hlkA:32.2 | 5a5zC-1hlkA:29.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5A5Z_C_WJZC304_0 (BETA-LACTAMASE NDM-1) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 4 / 7 | HIS A 162LYS A 184GLY A 192ASN A 193 | ZN A1001 (-3.3A)113 A2002 (-3.6A)113 A2002 ( 3.8A)113 A2002 (-4.1A) | 0.82A | 5a5zC-1hlkA:32.2 | 5a5zC-1hlkA:29.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AMI_B_EF2B151_1 (CEREBLON ISOFORM 4) |
6az1 | RIBOSOMAL PROTEINS7E (Leishmaniadonovani) | 4 / 8 | ASN I 191PRO I 192SER I 198TRP I 190 | NoneNone U 11361 ( 3.7A) U 11361 ( 3.6A) | 1.36A | 5amiB-6az1I:undetectable | 5amiB-6az1I:17.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AYA_A_X8ZA307_1 (METALLO-BETA-LACTAMASE) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 5 / 11 | HIS A 99HIS A 101ASP A 103HIS A 162HIS A 223 | ZN A1001 (-3.4A) ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A)113 A2002 ( 3.6A) | 0.80A | 5ayaA-1hlkA:18.7 | 5ayaA-1hlkA:21.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5C0O_E_SAME301_0 (TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASETRMI) |
5ep8 | PYRIMIDINE-NUCLEOSIDE PHOSPHORYLASE (Bacillussubtilis) | 5 / 12 | GLY A 364GLY A 115GLY A 113ALA A 358HIS A 116 | GLY A 364 ( 0.0A)GLY A 115 ( 0.0A)GLY A 113 ( 0.0A)ALA A 358 ( 0.0A)HIS A 116 ( 1.0A) | 1.07A | 5c0oE-5ep8A:undetectable | 5c0oE-5ep8A:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXB_A_ESTA1000_1 (ESTROGEN RECEPTOR) |
3wd7 | TYPE III POLYKETIDESYNTHASES ACRIDONESYNTHASE (Citrusxmicrocarpa) | 5 / 10 | LEU A 222ALA A 113GLU A 116ARG A 234LEU A 187 | LEU A 222 ( 0.6A)ALA A 113 ( 0.0A)GLU A 116 ( 0.5A)ARG A 234 ( 0.6A)LEU A 187 ( 0.5A) | 1.23A | 5dxbA-3wd7A:undetectable | 5dxbA-3wd7A:22.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_P_BEZP801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
1jzn | GALACTOSE-SPECIFICLECTIN (Crotalusatrox) | 4 / 5 | SER A 42ALA A 41HIS A 44LEU A 13 | NA A1139 (-2.9A)NoneNoneNone | 1.21A | 5dzkb-1jznA:undetectable5dzkp-1jznA:undetectable | 5dzkb-1jznA:18.025dzkp-1jznA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_P_BEZP801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
2y1b | PUTATIVE OUTERMEMBRANE PROTEIN,SIGNAL (Escherichiacoli) | 4 / 5 | SER A 127ALA A 128HIS A 107MET A 92 | NoneNoneI3C A1133 (-3.6A)None | 1.03A | 5dzkb-2y1bA:undetectable5dzkp-2y1bA:undetectable | 5dzkb-2y1bA:20.725dzkp-2y1bA:2.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_P_BEZP801_1 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
1jzn | GALACTOSE-SPECIFICLECTIN (Crotalusatrox) | 4 / 6 | SER A 42ALA A 41HIS A 44LEU A 13 | NA A1139 (-2.9A)NoneNoneNone | 1.25A | 5dzkB-1jznA:undetectable5dzkP-1jznA:undetectable | 5dzkB-1jznA:18.025dzkP-1jznA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_P_BEZP801_1 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
2y1b | PUTATIVE OUTERMEMBRANE PROTEIN,SIGNAL (Escherichiacoli) | 4 / 6 | SER A 127ALA A 128HIS A 107MET A 92 | NoneNoneI3C A1133 (-3.6A)None | 1.02A | 5dzkB-2y1bA:undetectable5dzkP-2y1bA:undetectable | 5dzkB-2y1bA:20.725dzkP-2y1bA:2.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_Q_BEZQ801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
1jzn | GALACTOSE-SPECIFICLECTIN (Crotalusatrox) | 4 / 5 | SER A 42ALA A 41HIS A 44LEU A 13 | NA A1139 (-2.9A)NoneNoneNone | 1.20A | 5dzkc-1jznA:undetectable5dzkq-1jznA:undetectable | 5dzkc-1jznA:18.025dzkq-1jznA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_Q_BEZQ801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
2y1b | PUTATIVE OUTERMEMBRANE PROTEIN,SIGNAL (Escherichiacoli) | 4 / 5 | SER A 127ALA A 128HIS A 107MET A 92 | NoneNoneI3C A1133 (-3.6A)None | 1.02A | 5dzkc-2y1bA:undetectable5dzkq-2y1bA:undetectable | 5dzkc-2y1bA:20.725dzkq-2y1bA:2.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_R_BEZR801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
1jzn | GALACTOSE-SPECIFICLECTIN (Crotalusatrox) | 4 / 7 | SER A 42ALA A 41HIS A 44LEU A 13 | NA A1139 (-2.9A)NoneNoneNone | 1.02A | 5dzkD-1jznA:undetectable5dzkR-1jznA:undetectable | 5dzkD-1jznA:18.025dzkR-1jznA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_R_BEZR801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
2y1b | PUTATIVE OUTERMEMBRANE PROTEIN,SIGNAL (Escherichiacoli) | 4 / 7 | SER A 127ALA A 128HIS A 107MET A 92 | NoneNoneI3C A1133 (-3.6A)None | 1.02A | 5dzkD-2y1bA:undetectable5dzkR-2y1bA:undetectable | 5dzkD-2y1bA:20.725dzkR-2y1bA:2.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_T_BEZT801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
1jzn | GALACTOSE-SPECIFICLECTIN (Crotalusatrox) | 4 / 5 | SER A 42ALA A 41HIS A 44LEU A 13 | NA A1139 (-2.9A)NoneNoneNone | 1.02A | 5dzkf-1jznA:undetectable5dzkt-1jznA:undetectable | 5dzkf-1jznA:18.025dzkt-1jznA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_T_BEZT801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
2y1b | PUTATIVE OUTERMEMBRANE PROTEIN,SIGNAL (Escherichiacoli) | 4 / 5 | SER A 127ALA A 128HIS A 107MET A 92 | NoneNoneI3C A1133 (-3.6A)None | 1.03A | 5dzkf-2y1bA:undetectable5dzkt-2y1bA:undetectable | 5dzkf-2y1bA:20.725dzkt-2y1bA:2.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_T_BEZT801_1 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
1jzn | GALACTOSE-SPECIFICLECTIN (Crotalusatrox) | 4 / 8 | SER A 42ALA A 41HIS A 44LEU A 13 | NA A1139 (-2.9A)NoneNoneNone | 1.15A | 5dzkF-1jznA:undetectable5dzkT-1jznA:undetectable | 5dzkF-1jznA:18.025dzkT-1jznA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_U_BEZU801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
1jzn | GALACTOSE-SPECIFICLECTIN (Crotalusatrox) | 4 / 6 | SER A 42ALA A 41HIS A 44LEU A 13 | NA A1139 (-2.9A)NoneNoneNone | 1.16A | 5dzkg-1jznA:undetectable5dzku-1jznA:undetectable | 5dzkg-1jznA:18.025dzku-1jznA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_U_BEZU801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
2y1b | PUTATIVE OUTERMEMBRANE PROTEIN,SIGNAL (Escherichiacoli) | 4 / 6 | SER A 127ALA A 128HIS A 107MET A 92 | NoneNoneI3C A1133 (-3.6A)None | 1.03A | 5dzkg-2y1bA:undetectable5dzku-2y1bA:undetectable | 5dzkg-2y1bA:20.725dzku-2y1bA:2.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EWU_B_BEZB1401_0 (MAGNESIUM-CHELATASESUBUNIT CHLH,CHLOROPLASTIC) |
3p8c | NCK-ASSOCIATEDPROTEIN 1 (Homosapiens) | 5 / 6 | GLY B 911THR B 908SER B 915VAL B 912HIS B1030 | None CL B1130 ( 4.7A)NoneNoneNone | 1.27A | 5ewuB-3p8cB:undetectable | 5ewuB-3p8cB:17.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GSM_A_GCSA801_1 (EXO-BETA-D-GLUCOSAMINIDASE) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 5 / 12 | TYR A 96GLU A 142GLU A 200GLU A 298TYR A 342 | GAL A1130 (-4.7A)GAL A1130 ( 2.8A)GAL A1130 (-2.4A)GAL A1130 (-2.4A)GAL A1130 (-4.2A) | 0.68A | 5gsmA-4iugA:31.2 | 5gsmA-4iugA:23.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GSM_B_GCSB801_1 (EXO-BETA-D-GLUCOSAMINIDASE) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 5 / 12 | TYR A 96GLU A 142GLU A 200GLU A 298TYR A 342 | GAL A1130 (-4.7A)GAL A1130 ( 2.8A)GAL A1130 (-2.4A)GAL A1130 (-2.4A)GAL A1130 (-4.2A) | 0.68A | 5gsmB-4iugA:32.1 | 5gsmB-4iugA:23.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H8T_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 12 | PHE A 17TYR A 20ALA A 34ILE A 52SER A 56 | NoneNone NA A1132 ( 4.0A)None NA A1132 (-2.9A) | 0.62A | 5h8tA-4a60A:19.2 | 5h8tA-4a60A:30.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H8T_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19TYR A 22LEU A 32ALA A 36SER A 58 | NoneNoneA9M A1136 ( 4.1A)A9M A1136 (-3.4A)A9M A1136 ( 4.1A) | 0.80A | 5h8tA-4azpA:20.7 | 5h8tA-4azpA:33.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 7 / 12 | PHE A 17TYR A 20VAL A 26ALA A 34PRO A 39ILE A 52SER A 56 | NoneNoneNone NA A1132 ( 4.0A)NoneNone NA A1132 (-2.9A) | 0.63A | 5hbsA-4a60A:19.0 | 5hbsA-4a60A:30.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19TYR A 22VAL A 28ALA A 36SER A 58 | NoneNoneNoneA9M A1136 (-3.4A)A9M A1136 ( 4.1A) | 0.77A | 5hbsA-4azpA:20.6 | 5hbsA-4azpA:33.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | TYR A 22VAL A 28LEU A 32ALA A 36SER A 58 | NoneNoneA9M A1136 ( 4.1A)A9M A1136 (-3.4A)A9M A1136 ( 4.1A) | 0.87A | 5hbsA-4azpA:20.6 | 5hbsA-4azpA:33.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IGY_A_ERYA403_1 (MACROLIDE2'-PHOSPHOTRANSFERASE II) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 4 / 6 | ASP A 80ILE A 85TYR A 379TYR A 603 | NoneNoneNoneNAG A1137 (-4.7A) | 1.48A | 5igyA-4iugA:2.3 | 5igyA-4iugA:14.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JS5_A_ASCA202_0 (CYTOCHROME C') |
4cx9 | CYTOCHROME C, CLASSII (Shewanellafrigidimarina) | 3 / 3 | CYH A 118LYS A 119HIS A 122 | HEC A1129 (-1.9A)None NO A1130 (-4.8A) | 0.31A | 5js5A-4cx9A:19.8 | 5js5A-4cx9A:42.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KMF_A_6U9A1301_1 (ION TRANSPORTPROTEIN) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 4 / 6 | THR B 720GLY B 653PHE B 652ILE A 462 | CLA B9010 (-3.5A)NoneBCR A6017 ( 4.5A)CLA A1132 ( 4.1A) | 0.94A | 5kmfA-4rkuB:undetectable5kmfC-4rkuB:2.9 | 5kmfA-4rkuB:17.305kmfC-4rkuB:17.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KXI_A_NCTA402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 4 / 8 | TYR B 670THR A 552CYH A 450LEU A 446 | CLA B9023 (-4.2A)CLA A1124 (-3.5A)CLA B9023 (-4.2A)CLA A1137 ( 3.6A) | 1.44A | 5kxiA-4rkuB:2.65kxiB-4rkuB:4.3 | 5kxiA-4rkuB:19.845kxiB-4rkuB:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KXI_D_NCTD402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 4 / 8 | TYR B 670THR A 552CYH A 450LEU A 446 | CLA B9023 (-4.2A)CLA A1124 (-3.5A)CLA B9023 (-4.2A)CLA A1137 ( 3.6A) | 1.41A | 5kxiD-4rkuB:2.75kxiE-4rkuB:4.3 | 5kxiD-4rkuB:19.845kxiE-4rkuB:18.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L8R_B_PQNB841_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | TRP A 55MET A 691SER A 695ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.73A | 5l8rB-4rkuA:34.1 | 5l8rB-4rkuA:46.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LF3_H_BO2H306_1 (PROTEASOME SUBUNITBETA TYPE-7PROTEASOME SUBUNITBETA TYPE-3) |
2wp4 | MOLYBDOPTERIN-CONVERTING FACTOR SUBUNIT2 1 (Mycobacteriumtuberculosis) | 5 / 10 | ALA A 28GLU A 24ALA A 105GLY A 104ALA A 86 | NoneGOL A1138 (-2.7A)NoneNoneNone | 1.11A | 5lf3H-2wp4A:undetectable5lf3I-2wp4A:undetectable | 5lf3H-2wp4A:21.495lf3I-2wp4A:21.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LF3_V_BO2V303_1 (PROTEASOME SUBUNITBETA TYPE-7PROTEASOME SUBUNITBETA TYPE-3) |
2wp4 | MOLYBDOPTERIN-CONVERTING FACTOR SUBUNIT2 1 (Mycobacteriumtuberculosis) | 5 / 10 | ALA A 28GLU A 24ALA A 105GLY A 104ALA A 86 | NoneGOL A1138 (-2.7A)NoneNoneNone | 1.14A | 5lf3V-2wp4A:undetectable5lf3W-2wp4A:undetectable | 5lf3V-2wp4A:21.495lf3W-2wp4A:21.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 12 | PHE A 17TYR A 20ALA A 34PRO A 39SER A 56 | NoneNone NA A1132 ( 4.0A)None NA A1132 (-2.9A) | 0.79A | 5ljbA-4a60A:19.3 | 5ljbA-4a60A:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19TYR A 22LEU A 32ALA A 36SER A 58 | NoneNoneA9M A1136 ( 4.1A)A9M A1136 (-3.4A)A9M A1136 ( 4.1A) | 0.98A | 5ljbA-4azpA:20.6 | 5ljbA-4azpA:34.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJC_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homosapiens) | 5 / 12 | PHE A 17TYR A 20ALA A 34PRO A 39SER A 56 | NoneNone NA A1132 ( 4.0A)None NA A1132 (-2.9A) | 0.78A | 5ljcA-4a60A:19.4 | 5ljcA-4a60A:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJC_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
4azp | FATTY ACID-BINDINGPROTEIN, EPIDERMAL (Musmusculus) | 5 / 12 | PHE A 19TYR A 22LEU A 32ALA A 36SER A 58 | NoneNoneA9M A1136 ( 4.1A)A9M A1136 (-3.4A)A9M A1136 ( 4.1A) | 0.99A | 5ljcA-4azpA:20.8 | 5ljcA-4azpA:34.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJE_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1o8v | FATTY ACID BINDINGPROTEIN HOMOLOG (Echinococcusgranulosus) | 5 / 12 | PHE A 16PRO A 38LEU A 40SER A 56PHE A 58 | PLM A1136 (-4.7A)NoneNonePLM A1136 ( 3.8A)PLM A1136 ( 4.9A) | 1.09A | 5ljeA-1o8vA:19.9 | 5ljeA-1o8vA:32.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LUR_B_STRB201_1 (AVIDIN) |
4bx7 | STREPTAVIDIN (Streptomycesavidinii) | 5 / 11 | TYR A 43ALA A 45TRP A 79THR A 90TRP A 108 | MPD A1134 (-4.7A)NoneMPD A1134 (-4.4A)MPD A1134 (-3.1A)MPD A1134 (-3.8A) | 0.49A | 5lurB-4bx7A:15.9 | 5lurB-4bx7A:29.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MRA_B_DM2B204_1 (SORCIN) |
2cjt | UNC-13 HOMOLOG A (Rattusnorvegicus) | 4 / 6 | PHE A 20THR A 22ASP A 72GLY A 68 | NoneNoneEDO A1134 (-2.9A)FMT A1137 ( 3.1A) | 1.03A | 5mraA-2cjtA:undetectable5mraB-2cjtA:undetectable | 5mraA-2cjtA:23.165mraB-2cjtA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MXB_A_ML1A220_1 (CLASS 10 PLANTPATHOGENESIS-RELATEDPROTEIN) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 5 / 9 | TYR A 603LEU A 72TYR A 987THR A 985VAL A 983 | NAG A1137 (-4.7A)NoneNoneNoneNone | 1.40A | 5mxbA-4iugA:undetectable | 5mxbA-4iugA:5.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5D_B_SAMB303_1 (METHYLTRANSFERASE) |
2ymz | GALECTIN 2 (Gallusgallus) | 4 / 7 | GLY A 121PHE A 31SER A 25ASN A 118 | NoneNoneSO4 A1132 ( 3.9A)None | 1.01A | 5n5dB-2ymzA:undetectable | 5n5dB-2ymzA:19.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NNW_D_GCSD302_1 (25 KDA PROTEINELICITOR) |
4nen | INTEGRIN ALPHA-X (Homosapiens) | 4 / 7 | ASP A 519GLY A 539HIS A 538ASP A 511 | CA A1113 (-2.0A)NoneNone CA A1113 (-3.2A) | 1.05A | 5nnwD-4nenA:undetectable | 5nnwD-4nenA:5.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O96_G_SAMG501_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) |
3ab7 | PUTATIVEUNCHARACTERIZEDPROTEIN TTHA0350 (Thermusthermophilus) | 5 / 11 | LEU A 115GLY A 15LEU A 113THR A 7ALA A 6 | LEU A 115 ( 0.6A)GLY A 15 ( 0.0A)LEU A 113 ( 0.6A)THR A 7 ( 0.8A)ALA A 6 ( 0.0A) | 1.03A | 5o96G-3ab7A:undetectable | 5o96G-3ab7A:26.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O96_H_SAMH501_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) |
3ab7 | PUTATIVEUNCHARACTERIZEDPROTEIN TTHA0350 (Thermusthermophilus) | 5 / 10 | LEU A 115GLY A 15LEU A 113THR A 7ALA A 6 | LEU A 115 ( 0.6A)GLY A 15 ( 0.0A)LEU A 113 ( 0.6A)THR A 7 ( 0.8A)ALA A 6 ( 0.0A) | 1.08A | 5o96G-3ab7A:undetectable5o96H-3ab7A:2.0 | 5o96G-3ab7A:26.045o96H-3ab7A:26.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OEX_A_CUA602_0 (THIOCYANATEDEHYDROGENASE) |
4dvk | E(RNS) GLYCOPROTEIN (PestivirusA) | 3 / 3 | LYS A 80HIS A 76HIS A 81 | SO4 A1112 (-2.5A)SO4 A1113 ( 3.9A)SO4 A1112 (-3.7A) | 1.38A | 5oexA-4dvkA:undetectable | 5oexA-4dvkA:16.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OEX_B_CUB602_0 (THIOCYANATEDEHYDROGENASE) |
4dvk | E(RNS) GLYCOPROTEIN (PestivirusA) | 3 / 3 | LYS A 80HIS A 76HIS A 81 | SO4 A1112 (-2.5A)SO4 A1113 ( 3.9A)SO4 A1112 (-3.7A) | 1.38A | 5oexB-4dvkA:undetectable | 5oexB-4dvkA:16.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OEX_C_CUC603_0 (THIOCYANATEDEHYDROGENASE) |
4dvk | E(RNS) GLYCOPROTEIN (PestivirusA) | 3 / 3 | LYS A 80HIS A 76HIS A 81 | SO4 A1112 (-2.5A)SO4 A1113 ( 3.9A)SO4 A1112 (-3.7A) | 1.39A | 5oexC-4dvkA:undetectable | 5oexC-4dvkA:16.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OEX_D_CUD603_0 (THIOCYANATEDEHYDROGENASE) |
4dvk | E(RNS) GLYCOPROTEIN (PestivirusA) | 3 / 3 | LYS A 80HIS A 76HIS A 81 | SO4 A1112 (-2.5A)SO4 A1113 ( 3.9A)SO4 A1112 (-3.7A) | 1.39A | 5oexD-4dvkA:undetectable | 5oexD-4dvkA:16.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OY0_2_PQN2843_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 9 / 12 | TRP A 55MET A 691PHE A 692SER A 695ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.57A | 5oy02-4rkuA:34.1 | 5oy02-4rkuA:12.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OY0_2_PQN2843_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 9 / 12 | ILE B 21MET B 662PHE B 663SER B 666TRP B 667ARG B 668TRP B 671LEU B 700ALA B 705 | CLA A1131 ( 4.4A)CLA B9023 ( 3.3A)PQN B5002 ( 4.3A)PQN B5002 (-3.2A)NoneNonePQN B5002 ( 3.3A)PQN B5002 (-3.7A)PQN B5002 (-3.4A) | 1.48A | 5oy02-4rkuB:43.3 | 5oy02-4rkuB:11.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OY0_B_PQNB1844_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 8 / 10 | MET A 691PHE A 692SER A 695ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.65A | 5oy0b-4rkuA:34.2 | 5oy0b-4rkuA:7.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TE8_A_08JA602_1 (CYTOCHROME P450 3A4) |
2w6l | COBE (Pseudomonasaeruginosa) | 4 / 7 | SER A 98ALA A 131THR A 31LEU A 27 | SO4 A1138 (-2.5A)NoneNoneNone | 0.84A | 5te8A-2w6lA:undetectable | 5te8A-2w6lA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TE8_B_08JB602_1 (CYTOCHROME P450 3A4) |
2w6l | COBE (Pseudomonasaeruginosa) | 4 / 8 | SER A 98ALA A 131THR A 31LEU A 27 | SO4 A1138 (-2.5A)NoneNoneNone | 0.79A | 5te8B-2w6lA:undetectable | 5te8B-2w6lA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TE8_C_08JC602_1 (CYTOCHROME P450 3A4) |
2w6l | COBE (Pseudomonasaeruginosa) | 4 / 7 | SER A 98ALA A 131THR A 31LEU A 27 | SO4 A1138 (-2.5A)NoneNoneNone | 0.82A | 5te8C-2w6lA:undetectable | 5te8C-2w6lA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TT3_G_EZLG303_1 (ALPHA-CARBONICANHYDRASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 9 | HIS A 94HIS A 96HIS A 53VAL A 118ALA A 108 | MN A1132 (-3.6A) MN A1132 (-3.4A) MN A1132 (-3.3A)NoneNone | 1.49A | 5tt3G-4bifA:undetectable | 5tt3G-4bifA:19.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UC1_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
2xgy | RELIK CAPSIDN-TERMINAL DOMAIN (Oryctolaguscuniculus) | 3 / 3 | TRP A 22MET A 54ASN A 57 | NoneNoneGOL A1138 (-4.0A) | 1.48A | 5uc1A-2xgyA:undetectable | 5uc1A-2xgyA:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VKQ_C_PCFC1803_0 (NO MECHANORECEPTORPOTENTIAL C ISOFORML) |
3eqz | RESPONSE REGULATOR (Colwelliapsychrerythraea) | 4 / 8 | SER A 120PHE A 26VAL A 113ILE A 50 | SER A 120 ( 0.0A)PHE A 26 ( 1.3A)VAL A 113 ( 0.6A)ILE A 50 ( 0.7A) | 1.11A | 5vkqB-3eqzA:undetectable5vkqC-3eqzA:undetectable | 5vkqB-3eqzA:5.665vkqC-3eqzA:5.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_C_CVIC301_0 (REGULATORY PROTEINTETR) |
5dm6 | 50S RIBOSOMALPROTEIN L13 (Deinococcusradiodurans) | 5 / 12 | MET G 134ALA G 130GLU G 124LEU G 148VAL G 88 | G X1137 ( 4.0A) G X1138 ( 3.2A)NoneNoneNone | 1.45A | 5vlmC-5dm6G:undetectable | 5vlmC-5dm6G:20.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_H_CVIH301_0 (REGULATORY PROTEINTETR) |
5dm6 | 50S RIBOSOMALPROTEIN L13 (Deinococcusradiodurans) | 5 / 12 | MET G 134ALA G 130GLU G 124LEU G 148VAL G 88 | G X1137 ( 4.0A) G X1138 ( 3.2A)NoneNoneNone | 1.33A | 5vlmH-5dm6G:undetectable | 5vlmH-5dm6G:20.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_H_CVIH301_1 (REGULATORY PROTEINTETR) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum;Pisumsativum) | 4 / 8 | GLY A 698ILE A 704GLN A 721ASP B 540 | NoneCLA A1139 ( 4.5A)NoneNone | 1.01A | 5vlmH-4rkuA:undetectable | 5vlmH-4rkuA:13.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
2vzp | EXO-BETA-D-GLUCOSAMINIDASE (Amycolatopsisorientalis) | 4 / 7 | ASN A 21HIS A 22GLY A 119ASN A 121 | NoneNoneNoneEDO A1130 (-3.4A) | 1.03A | 5x7pA-2vzpA:8.7 | 5x7pA-2vzpA:6.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
2vzp | EXO-BETA-D-GLUCOSAMINIDASE (Amycolatopsisorientalis) | 4 / 7 | ASN A 21HIS A 22TRP A 90ASN A 121 | NoneNoneNoneEDO A1130 (-3.4A) | 0.33A | 5x7pA-2vzpA:8.7 | 5x7pA-2vzpA:6.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) | 4 / 7 | ASP A 998TRP A1051GLY A1081ASN A1083 | GLC A1113 (-4.0A)GLC A1112 (-3.6A)GLC A1113 (-3.2A)GLC A1112 (-2.9A) | 0.93A | 5x7pA-5f7uA:20.9 | 5x7pA-5f7uA:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) | 4 / 7 | HIS A 985TRP A1051GLY A1081ASN A1083 | GLC A1112 (-3.9A)GLC A1112 (-3.6A)GLC A1113 (-3.2A)GLC A1112 (-2.9A) | 0.52A | 5x7pA-5f7uA:20.9 | 5x7pA-5f7uA:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_B_ACRB1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) | 4 / 5 | ASP A 998TRP A1051GLY A1081ASN A1083 | GLC A1113 (-4.0A)GLC A1112 (-3.6A)GLC A1113 (-3.2A)GLC A1112 (-2.9A) | 0.91A | 5x7pB-5f7uA:22.7 | 5x7pB-5f7uA:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_B_ACRB1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) | 4 / 5 | HIS A 985TRP A1051GLY A1081ASN A1083 | GLC A1112 (-3.9A)GLC A1112 (-3.6A)GLC A1113 (-3.2A)GLC A1112 (-2.9A) | 0.51A | 5x7pB-5f7uA:22.7 | 5x7pB-5f7uA:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X80_A_SALA201_1 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 4 / 5 | VAL A 319PRO A 261GLY A 263TYR A 260 | NoneNoneNoneGAL A1130 (-4.5A) | 1.00A | 5x80A-4iugA:undetectable5x80B-4iugA:undetectable | 5x80A-4iugA:10.465x80B-4iugA:10.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X80_B_SALB203_1 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 4 / 6 | PRO A 261GLY A 263TYR A 260LEU A 318 | NoneNoneGAL A1130 (-4.5A)None | 0.95A | 5x80A-4iugA:undetectable5x80B-4iugA:undetectable | 5x80A-4iugA:10.465x80B-4iugA:10.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X80_C_SALC201_1 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 4 / 7 | VAL A 319PRO A 261GLY A 263TYR A 260 | NoneNoneNoneGAL A1130 (-4.5A) | 1.01A | 5x80C-4iugA:undetectable5x80D-4iugA:undetectable | 5x80C-4iugA:10.465x80D-4iugA:10.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X80_D_SALD201_1 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) |
4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) | 4 / 5 | PRO A 261GLY A 263TYR A 260VAL A 319 | NoneNoneGAL A1130 (-4.5A)None | 0.97A | 5x80C-4iugA:undetectable5x80D-4iugA:undetectable | 5x80C-4iugA:10.465x80D-4iugA:10.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XDH_C_DAHC60_1 (PUTATIVE CYTOCHROMEC) |
2bj8 | NICKEL RESPONSIVEREGULATOR (Pyrococcushorikoshii) | 4 / 6 | HIS A 89ASN A 63VAL A 69LEU A 74 | NI A1137 (-3.3A)NoneNoneNone | 1.10A | 5xdhA-2bj8A:undetectable5xdhC-2bj8A:undetectable | 5xdhA-2bj8A:19.575xdhC-2bj8A:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZGB_B_PQNB844_1 (PSAB) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | ILE A 54TRP A 55MET A 691ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1101 ( 3.9A)CLA A1139 (-4.1A)CLA A9013 ( 3.6A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 1.13A | 5zgbB-4rkuA:39.3 | 5zgbB-4rkuA:6.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZGB_B_PQNB844_1 (PSAB) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 8 / 9 | ILE B 21TRP B 22MET B 662ARG B 668TRP B 671ALA B 699LEU B 700ALA B 705 | CLA A1131 ( 4.4A)CLA B1238 ( 4.0A)CLA B9023 ( 3.3A)NonePQN B5002 ( 3.3A)PQN B5002 (-3.2A)PQN B5002 (-3.7A)PQN B5002 (-3.4A) | 1.13A | 5zgbB-4rkuB:44.1 | 5zgbB-4rkuB:9.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZGB_B_PQNB844_1 (PSAB) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 8 / 9 | ILE B 21TRP B 22MET B 662TRP B 667ARG B 668ALA B 699LEU B 700ALA B 705 | CLA A1131 ( 4.4A)CLA B1238 ( 4.0A)CLA B9023 ( 3.3A)NoneNonePQN B5002 (-3.2A)PQN B5002 (-3.7A)PQN B5002 (-3.4A) | 0.57A | 5zgbB-4rkuB:44.1 | 5zgbB-4rkuB:9.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZGH_B_PQNB843_1 (PSAB) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | ILE A 54TRP A 55MET A 691ARG A 697TRP A 700ALA A 724LEU A 725 | CLA A1101 ( 3.9A)CLA A1139 (-4.1A)CLA A9013 ( 3.6A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 1.13A | 5zghB-4rkuA:33.3 | 5zghB-4rkuA:6.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZGH_B_PQNB843_1 (PSAB) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 7 / 9 | ILE B 21TRP B 22MET B 662ARG B 668TRP B 671ALA B 699LEU B 700 | CLA A1131 ( 4.4A)CLA B1238 ( 4.0A)CLA B9023 ( 3.3A)NonePQN B5002 ( 3.3A)PQN B5002 (-3.2A)PQN B5002 (-3.7A) | 1.22A | 5zghB-4rkuB:41.1 | 5zghB-4rkuB:9.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZGH_B_PQNB843_1 (PSAB) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Pisumsativum) | 8 / 9 | ILE B 21TRP B 22MET B 662TRP B 667ARG B 668ALA B 699LEU B 700ALA B 705 | CLA A1131 ( 4.4A)CLA B1238 ( 4.0A)CLA B9023 ( 3.3A)NoneNonePQN B5002 (-3.2A)PQN B5002 (-3.7A)PQN B5002 (-3.4A) | 0.61A | 5zghB-4rkuB:41.1 | 5zghB-4rkuB:9.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZJ8_A_9DCA303_0 (METALLO-BETA-LACTAMASE TYPE 2) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 6 / 8 | HIS A 101ASP A 103HIS A 162CYH A 181ASN A 193HIS A 223 | ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 (-4.1A)113 A2002 ( 3.6A) | 0.51A | 5zj8A-1hlkA:14.4 | 5zj8A-1hlkA:30.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZJI_A_PQNA844_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM IREACTION CENTERSUBUNIT IX) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 9 / 10 | MET A 691PHE A 692SER A 695GLY A 696ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A9013 ( 3.6A)PQN A5001 (-3.6A)PQN A5001 (-3.5A)PQN A5001 ( 4.1A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.49A | 5zjiA-4rkuA:51.65zjiJ-4rkuA:undetectable | 5zjiA-4rkuA:98.045zjiJ-4rkuA:5.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZJI_B_PQNB842_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 10 | TRP A 55MET A 691ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.66A | 5zjiB-4rkuA:40.2 | 5zjiB-4rkuA:7.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_A_CUA607_0 (TYROSINASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 3 / 3 | HIS A 53HIS A 94HIS A 55 | MN A1132 (-3.3A) MN A1132 (-3.6A) MN A1132 (-3.4A) | 0.46A | 5zrdA-4bifA:undetectable | 5zrdA-4bifA:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_A_CUA607_0 (TYROSINASE) |
5fq0 | KDGF (Halomonassp.) | 3 / 3 | HIS B 48HIS B 89HIS B 50 | FLC B1114 ( 3.3A) NI B1113 ( 3.3A) NI B1113 ( 3.3A) | 0.42A | 5zrdA-5fq0B:undetectable | 5zrdA-5fq0B:11.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_B_CUB606_0 (TYROSINASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 4 / 5 | HIS A 53HIS A 96HIS A 94HIS A 55 | MN A1132 (-3.3A) MN A1132 (-3.4A) MN A1132 (-3.6A) MN A1132 (-3.4A) | 1.07A | 5zrdB-4bifA:undetectable | 5zrdB-4bifA:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_C_CUC604_0 (TYROSINASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 4 / 4 | HIS A 53HIS A 96HIS A 94HIS A 55 | MN A1132 (-3.3A) MN A1132 (-3.4A) MN A1132 (-3.6A) MN A1132 (-3.4A) | 1.05A | 5zrdC-4bifA:undetectable | 5zrdC-4bifA:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_D_CUD607_0 (TYROSINASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 4 / 4 | HIS A 53HIS A 96HIS A 94HIS A 55 | MN A1132 (-3.3A) MN A1132 (-3.4A) MN A1132 (-3.6A) MN A1132 (-3.4A) | 1.05A | 5zrdD-4bifA:undetectable | 5zrdD-4bifA:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BKL_G_EU7G101_0 (MATRIX PROTEIN 2) |
4w65 | GLYCOSYL HYDROLASEFAMILY PROTEIN (Mycolicibacteriumfortuitum) | 5 / 9 | ALA A 113ALA A 253GLY A 122ALA A 255GLY A 92 | ALA A 113 ( 0.0A)ALA A 253 ( 0.0A)GLY A 122 ( 0.0A)ALA A 255 ( 0.0A)GLY A 92 ( 0.0A) | 1.19A | 6bklE-4w65A:undetectable6bklF-4w65A:undetectable6bklG-4w65A:undetectable6bklH-4w65A:undetectable | 6bklE-4w65A:5.736bklF-4w65A:5.736bklG-4w65A:5.736bklH-4w65A:5.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CE2_B_SVRB202_1 () |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 6 / 8 | LEU A1002LEU A1005GLY A1033ARG A1034LYS A1049TYR A1052 | IPA A1136 ( 4.7A)IPA A1135 ( 4.2A)NoneNoneNoneNone | 0.78A | 6ce2A-1mc2A:23.1 | 6ce2A-1mc2A:72.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CE2_B_SVRB202_1 () |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 6 / 8 | LEU A1002LEU A1005GLY A1033LYS A1049TYR A1052LYS A1069 | IPA A1136 ( 4.7A)IPA A1135 ( 4.2A)NoneNoneNoneNone | 0.64A | 6ce2A-1mc2A:23.1 | 6ce2A-1mc2A:72.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CE2_B_SVRB202_1 () |
1wqa | PHOSPHO-SUGAR MUTASE (Pyrococcushorikoshii) | 4 / 8 | LEU A 34LEU A 33LEU A 113GLY A 119 | LEU A 34 ( 0.6A)LEU A 33 ( 0.6A)LEU A 113 ( 0.6A)GLY A 119 ( 0.0A) | 0.77A | 6ce2A-1wqaA:undetectable | 6ce2A-1wqaA:11.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CE2_B_SVRB202_2 (-) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 6 / 12 | LEU A1002GLY A1023GLY A1030GLY A1033ARG A1034LYS A1049 | IPA A1136 ( 4.7A)IPA A1135 ( 4.1A)IPA A1135 ( 4.4A)NoneNoneNone | 1.27A | 6ce2B-1mc2A:22.7 | 6ce2B-1mc2A:72.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CE2_B_SVRB202_2 (-) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 5 / 12 | LEU A1002GLY A1023GLY A1030GLY A1033LYS A1049 | IPA A1136 ( 4.7A)IPA A1135 ( 4.1A)IPA A1135 ( 4.4A)NoneNone | 0.94A | 6ce2B-1mc2A:22.7 | 6ce2B-1mc2A:72.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CE2_B_SVRB202_2 (-) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 6 / 12 | LEU A1002LEU A1005GLY A1023GLY A1030GLY A1033TYR A1052 | IPA A1136 ( 4.7A)IPA A1135 ( 4.2A)IPA A1135 ( 4.1A)IPA A1135 ( 4.4A)NoneNone | 0.88A | 6ce2B-1mc2A:22.7 | 6ce2B-1mc2A:72.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CE2_B_SVRB202_2 (-) |
1mc2 | ACUTOHAEMONLYSIN (Deinagkistrodonacutus) | 6 / 12 | LEU A1005GLY A1023GLY A1030GLY A1033ARG A1034TYR A1052 | IPA A1135 ( 4.2A)IPA A1135 ( 4.1A)IPA A1135 ( 4.4A)NoneNoneNone | 0.54A | 6ce2B-1mc2A:22.7 | 6ce2B-1mc2A:72.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DEB_B_MTXB303_1 (BIFUNCTIONAL PROTEINFOLD) |
6fos | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Cyanidioschyzonmerolae) | 4 / 5 | TYR A 368GLN A 383GLY A 507ILE A 522 | NoneNoneNoneCLA A1135 ( 4.9A) | 1.45A | 6debB-6fosA:undetectable | 6debB-6fosA:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKZ_A_SNPA413_0 (AROMATICPEROXYGENASE) |
2vbt | RIBOFLAVIN KINASE (Methanocaldococcusjannaschii) | 4 / 7 | ASP A 122GLY A 16SER A 13GLY A 14 | NoneCDP A1137 ( 3.2A)NoneCDP A1137 (-3.6A) | 0.90A | 6ekzA-2vbtA:undetectable | 6ekzA-2vbtA:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FI4_B_DVAB8_0 (14-3-3 PROTEIN SIGMAPRO-SEP-LEU-PRO-DVA) |
5xxu | RIBOSOMAL PROTEINUS17 (Toxoplasmagondii) | 4 / 5 | SER L 67VAL L 66ASN L 141PRO L 133 | A 2 113 ( 2.6A)NoneNone U 2 335 ( 3.5A) | 1.17A | 6fi4A-5xxuL:undetectable6fi4B-5xxuL:undetectable | 6fi4A-5xxuL:19.516fi4B-5xxuL:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6FOS_A_PQNA2001_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 6 / 6 | TRP A 55MET A 691GLY A 696TRP A 700ALA A 724LEU A 725 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 ( 4.1A)PQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.65A | 6fosA-4rkuA:43.0 | 6fosA-4rkuA:86.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FOS_B_PQNB2002_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
2w3j | CARBOHYDRATE BINDINGMODULE (unculturedbacterium) | 4 / 6 | ARG A 67ALA A 119LEU A 118ALA A 112 | CA A1138 ( 4.5A)NoneNoneNone | 1.05A | 6fosB-2w3jA:undetectable | 6fosB-2w3jA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GH9_A_MIXA1003_0 (UBIQUITINCARBOXYL-TERMINALHYDROLASE 15) |
1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) | 4 / 5 | ASN A 55GLY A 192HIS A 223ASP A 103 | None113 A2002 ( 3.8A)113 A2002 ( 3.6A) ZN A1002 ( 3.3A) | 0.96A | 6gh9A-1hlkA:undetectable | 6gh9A-1hlkA:16.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GIQ_A_CUA601_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
1v15 | COLICIN E9 (Escherichiacoli) | 3 / 3 | HIS A 102HIS A 131HIS A 127 | ZN A1132 (-3.2A) ZN A1132 (-3.3A) ZN A1132 (-3.4A) | 0.73A | 6giqa-1v15A:undetectable | 6giqa-1v15A:12.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GIQ_A_CUA601_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 3 / 3 | HIS A 96HIS A 53HIS A 94 | MN A1132 (-3.4A) MN A1132 (-3.3A) MN A1132 (-3.6A) | 0.76A | 6giqa-4bifA:undetectable | 6giqa-4bifA:12.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HQB_A_PQNA2001_0 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM IREACTION CENTERSUBUNIT IX) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 9 / 10 | TRP A 55MET A 691SER A 695GLY A 696ARG A 697TRP A 700ALA A 724LEU A 725GLY A 730 | CLA A1139 (-4.1A)CLA A9013 ( 3.6A)PQN A5001 (-3.5A)PQN A5001 ( 4.1A)NonePQN A5001 ( 3.4A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A)PQN A5001 ( 4.0A) | 0.30A | 6hqbA-4rkuA:50.26hqbJ-4rkuA:undetectable | 6hqbA-4rkuA:23.536hqbJ-4rkuA:6.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HQB_B_PQNB2002_0 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
4rku | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 (Pisumsativum) | 7 / 9 | MET A 691SER A 695ARG A 697TRP A 700ILE A 704ALA A 724LEU A 725 | CLA A9013 ( 3.6A)PQN A5001 (-3.5A)NonePQN A5001 ( 3.4A)CLA A1139 ( 4.5A)PQN A5001 (-3.4A)PQN A5001 ( 3.7A) | 0.65A | 6hqbB-4rkuA:33.8 | 6hqbB-4rkuA:12.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HU9_H_PCFH604_0 (CYTOCHROME B-C1COMPLEX SUBUNIT 8CYTOCHROME C OXIDASEPOLYPEPTIDE 5A,MITOCHONDRIAL) |
2w6l | COBE (Pseudomonasaeruginosa) | 4 / 8 | GLY A 50GLY A 14SER A 47ALA A 46 | GOL A1141 (-4.5A)SO4 A1138 ( 3.7A)NoneNone | 0.75A | 6hu9H-2w6lA:undetectable6hu9e-2w6lA:undetectable | 6hu9H-2w6lA:16.906hu9e-2w6lA:20.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6QGB_B_BEZB802_0 (MONO(2-HYDROXYETHYL)TEREPHTHALATEHYDROLASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 10 | GLY A 97LEU A 61ALA A 108PHE A 44HIS A 53 | NoneNoneNoneNone MN A1132 (-3.3A) | 1.01A | 6qgbB-4bifA:undetectable | 6qgbB-4bifA:15.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6QGB_D_BEZD701_0 (MONO(2-HYDROXYETHYL)TEREPHTHALATEHYDROLASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 10 | GLY A 97LEU A 61ALA A 108PHE A 44HIS A 53 | NoneNoneNoneNone MN A1132 (-3.3A) | 0.99A | 6qgbD-4bifA:undetectable | 6qgbD-4bifA:15.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6QGB_F_BEZF701_0 (MONO(2-HYDROXYETHYL)TEREPHTHALATEHYDROLASE) |
4bif | CUPIN 2 CONSERVEDBARREL DOMAINPROTEIN (Granulicellatundricola) | 5 / 10 | GLY A 97LEU A 61ALA A 108PHE A 44HIS A 53 | NoneNoneNoneNone MN A1132 (-3.3A) | 1.02A | 6qgbF-4bifA:undetectable | 6qgbF-4bifA:15.08 |